LncRNA name,Cancer name,Methods,Expression pattern,Pubmed ID,Remarks,No. of Transcript variants,NCBI Reference Number,Total No. of PQS,No. of 2G PQS,No. of 3G PQS,No. of 4G PQS,RefSeq status,Total No. of PQS.1,G4Hunter Scores of PQS,Similarity between PQS from QGRS mapper vs PQS from G4 hunter,Total No. of PQS.2,G4Hunter Scores of PQS.1,Similarity between PQS from QGRS mapper vs PQS from G4 hunter.1
AFAP1-AS1,cervical cancer,RNA-seq,up-regulated,30816545,"Also Known As: AFAP1-AS, AFAP1AS",1,NR_026892.1,37,36,1,0,VALIDATED,"9 (1-3G,8-C-rich) ","['-0.872, -0.898, -0.855, -0.894, -0.958, -0.796, -0.672, -0.872(C-rich);  0.911 (3G)]",The 3G PQS of G4 Hunter and QGRS mapper is similar and the main G tract of both PQS is the same with additional nucleotides surrounding in the G4 hunter PQS,0,0,No PQS found in G4 hunter
ANRASSF1,cervical cancer,"RNA-seq, qPCR, RNAi, Western blot, RIP, ChIP, Cell proliferation assay etc.",differential expression,23990798,Also known as: RASSF1-AS1,1,NR_109831.1,11,8,3,0,VALIDATED,"10 (2-3G, 2-2G, 6-C-rich)","['0.911, 0.911 (3G); 0.82, 0.92 (2G); '-0.911, -0.872, -0.911, -0.683, -0.854, -0.924 (C-rich)]",The PQS 1 (3G) of QGRS mapper and the PQS 1 of G4 Hunter are both 3G and have the same G tracts with a right frame shift in G4 hunter compared to QGRS mapper.,0,0,No PQS found in G4 hunter
"ANRIL
CDKN2B-AS1",cervical cancer,"qPCR, RNAi etc.",up-regulated,26408699,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)",REVIEWED,"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",-0.829 (C-rich),All the variants had one PQS with the same score,0,0,No PQS found in G4 hunter
"ANRIL
CDKN2B-AS1",cervical cancer,qPCR etc.,up-regulated,22487937,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)",REVIEWED,"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",-0.829 (C-rich),All the variants had one PQS with the same score,0,0,No PQS found in G4 hunter
"ANRIL
CDKN2B-AS1",cervical cancer,"qPCR, Luciferase Reporter Assay",up-regulated,28550682,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)",REVIEWED,"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",-0.829 (C-rich),All the variants had one PQS with the same score,0,0,No PQS found in G4 hunter
"ANRIL
CDKN2B-AS1",cervical cancer,"qPCR, RNAi, Western blot, Cell proliferation assay etc.",up-regulated,27899255,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)",REVIEWED,"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",-0.829 (C-rich),All the variants had one PQS with the same score,0,0,No PQS found in G4 hunter
ASB16-AS1,cervical cancer,"qRT-PCR, Western blot",up-regulated,32058219,Also known as: C17orf65,2,"NR_049729.1, NR_049730.1","20,4","19,4","1,0","0,0",VALIDATED,"10 (10-C-rich);
2 (2-C-rich)
","[-0.911, -0.86, -0.882, -0.933, -0.872, -0.914, -0.982, -0.942, -0.88, -0.84 (C-rich)] ; 

[-0.911, -0.84 (C-rich)]",,0,0,No PQS found in G4 hunter
"BC200
BCYRN1",cervical cancer,"Northern hybridization, ISH etc.",up-regulated,9422992,Also Known As: BCYRN1; BC200; BC200a; LINC00004; NCRNA00004,1 (BCYRN1),BCYRN1 (NR_001568.1),2 (BCYRN1),2 (BCYRN1),0 (BCYRN1),0 (BCYRN1),REVIEWED (BCYRN1),1 (C-rich),-1.135 (C-rich),,0,0,No PQS found in G4 hunter
BCAR4,cervical cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,29937186,,5,"NR_024049.1, NR_024050.1, NR_131216.1, NR_131217.1, NR_131222.1","5,2,1,2,2","5,2,1,2,2","0,0,0,0,0","0,0,0,0,0",VALIDATED,0,0,,0,0,No PQS found in G4 hunter
BCAR4,cervical cancer,"qPCR, Western blot, etc.",up-regulated,29937186,,5,"NR_024049.1, NR_024050.1, NR_131216.1, NR_131217.1, NR_131222.1","5,2,1,2,2","5,2,1,2,2","0,0,0,0,0","0,0,0,0,0",VALIDATED,0,0,,0,0,No PQS found in G4 hunter
BCYRN1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc.",up-regulated,29552212,Also Known As: BCYRN1; BC200; BC200a; LINC00004; NCRNA00004,1,NR_001568.1,2,2,0,0,VALIDATED,1 (C-rich),-1.135 (C-rich),,0,0,No PQS found in G4 hunter
BLACAT1,cervical squamous cell carcinoma,RT-PCR,up-regulated,32046460,Also Known As: BLACAT1; LINC00912; linc-UBC1; onco-lncRNA-30,1,NR_103783.1,21,21,0,0,VALIDATED,"6 (2-2G, 4-C-rich)","[0.821,0.922 (2G); '-0.815, 0.603, '-, -0.938, -0.891 (C-rich)]",,0,0,No PQS found in G4 hunter
BLACAT1,cervical cancer,"qPCR, Western blot",up-regulated,29863244,Also Known As: BLACAT1; LINC00912; linc-UBC1; onco-lncRNA-30,1,NR_103783.1,21,21,0,0,VALIDATED,"6 (2-2G, 4-C-rich)","[0.821,0.922 (2G); '-0.815, 0.603, '-, -0.938, -0.891 (C-rich)]",,0,0,No PQS found in G4 hunter
BLACAT1,cervical cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,29456724,Also Known As: BLACAT1; LINC00912; linc-UBC1; onco-lncRNA-30,1,NR_103783.1,21,21,0,0,VALIDATED,"6 (2-2G, 4-C-rich)","[0.821,0.922 (2G); '-0.815, 0.603, '-, -0.938, -0.891 (C-rich)]",,0,0,No PQS found in G4 hunter
BLACAT1,cervical cancer,"qPCR, RNAi, Western blot etc.",up-regulated,29863244,Also Known As: BLACAT1; LINC00912; linc-UBC1; onco-lncRNA-30,1,NR_103783.1,21,21,0,0,VALIDATED,"6 (2-2G, 4-C-rich)","[0.821,0.922 (2G); '-0.815, 0.603, '-, -0.938, -0.891 (C-rich)]",,0,0,No PQS found in G4 hunter
C5orf66-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP, etc.",up-regulated,30518760,Also known as: Epist,2,"NR_105049.1, NR_105050.1","9,9","8,8","1,1","0,0",VALIDATED,"8 (1-3G, 7-C-rich);
8 (1-3G, 7-C-rich)","[-0.915, -0.957, -0.935, -1.021, -1.261, , -0.828, -0.982 (C-rich) ; 0.979 (3G)] ; 

[-0.915, -0.957, -0.935, -1.021, -1.261, , -0.828, -0.982 (C-rich) ; 0.979 (3G)]",The PQS 1 (3G) of G4 Hunter and PQS 1 (3G) of QGRS mapper is similar and the main G tract of both PQS is the same with a right frame shift in G4 hunter compared to QGRS mapper.,"1 (C-rich);
1 (C-rich)","(-1.505 C-rich); 
(-1.505 C-rich)",No similarity to any PQS
CALML3-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,31298313,,2,"NR_120496.1, NR_120497.1","29,28","29,27","0,1","0,0",VALIDATED,"10 (1-2G, 9-C-rich);
10 (1-2G, 9-C-rich)","[(-0.833, -0.894, -1.043, - 0.878, -0.804, -0.911, -0.759, -0.907, -0.804 (C-rich); 0.802 (2G)] ;

[(-0.833, -0.894, -1.043, - 0.878, -0.804, -0.911, -0.759, -0.907, -0.804 (C-rich); 0.802 (2G)]",,"0,0","0,0",No PQS found in G4 hunter
CASC11,cervical cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,31255182,Also Known As: MYMLR; CARLO7; CARLo-7; LINC00990; TCONS_00014535,2,"NR_117101.1, NR_117102.1","3,3","0,0","0,0","0,0",VALIDATED,"1 (C-rich)
0",-0.724 (C-rich),,0,0,No PQS found in G4 hunter
CASC15,cervical cancer,"RT-qPCR, RIP",up-regulated,32016962,Also Known As: CACS15 [mentioned in title of paper (PubMed-31665008) refereed in NR_015410.2]; CASC15; CANT; LINC00340; lnc-SOX4-1,1,NR_015410.2,18,18,0,0,REVIEWED,0,0,,0,0,No PQS found in G4 hunter
CASC15,cervical cancer,qPCR,up-regulated,30720157,Also Known As: CACS15 [mentioned in title of paper (PubMed-31665008) refereed in NR_015410.2]; CASC15; CANT; LINC00340; lnc-SOX4-1,1,NR_015410.2,18,18,0,0,REVIEWED,0,0,,0,0,No PQS found in G4 hunter
CASC2,cervical cancer,"qRT-PCR , Western blot etc.",down-regulated,31081078,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17,17,9","15,5,7","2,2,2",0,VALIDATED,"7 (4- 3G, 3-2G);
7 (4- 3G, 3-2G);
6 (4 -3G, 2-2G)","[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 0.707(2G)] ;

[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 0.707(2G)] ;

[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 (2G)]","The PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have the same G tracts.

Similarly, the PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have the same G tracts.","0,0,0","0,0,0",No PQS found in G4 hunter
CASC2,cervical cancer,"qPCR, Western blot, Luciferase Reporter Assays",down-regulated,28495512,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17,17,9","15,5,7","2,2,2",0,VALIDATED,"7 (4- 3G, 3-2G);
7 (4- 3G, 3-2G);
6 (4 -3G, 2-2G)","[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 0.707(2G)] ;

[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 0.707(2G)] ;

[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 (2G)]","The PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have the same G tracts.

Similarly, the PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have the same G tracts.","0,0,0","0,0,0",No PQS found in G4 hunter
CASC9,cervical cancer,"RIP, Western blot , RT-qPCR etc.",down-regulated,31178137,Also Known As: ESSCAL1; ESCCAL-1; LINC00981; linc-JPH1,3,"NR_103848.1, NR_103850.2, NR_103849.2","5,4,4","5,4,4","0,0,0","0,0,0",VALIDATED,"0
0
1 (C-rich)",-0.857 (C-rich),,"0,0,0","0,0,0",No PQS found in G4 hunter
CCAT1,cervical cancer,"qRT-PCR, Western blot",up-regulated,31935379,Also Known As: CARLO5; CARLo-5; onco-lncRNA-40,1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter
CCAT1,cervical cancer,"qRT-PCR , in vitro knockdown etc.",up-regulated,31084453,Also Known As: CARLO5; CARLo-5; onco-lncRNA-40,1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter
CCAT1,cervical cancer,qPCR etc.,up-regulated,28849215,Also Known As: CARLO5; CARLo-5; onco-lncRNA-40,1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter
CCAT1,cervical cancer,"qPCR, Western blot etc.",up-regulated,28978096,Also Known As: CARLO5; CARLo-5; onco-lncRNA-40,1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter
CCAT2,cervical cancer,"qPCR, RNAi, Flow cytometry assay, Cell proliferation assay etc.",down-regulated,26983975,Also Known As: NCCP1; LINC00873,1,NR_109834.1,6,6,0,0,REVIEWED,0,0,,0,0,No PQS found in G4 hunter
CCAT2,cervical squamous cell carcinoma,qPCR etc.,up-regulated,26722527,Also Known As: NCCP1; LINC00873,1,NR_109834.1,6,6,0,0,REVIEWED,0,0,,0,0,No PQS found in G4 hunter
CCEPR,cervical cancer,"qPCR, Western blot etc.",up-regulated,29427865,Also Known As: CCEPR; CCHE1; lncRNA-CCHE1,1,NR_131782.1,17,17,0,0,VALIDATED,"2(1-C-rich, 1-2G)   ",['-0.939 (C-rich); 0.894 (2G)],,0,0,No PQS found in G4 hunter
CCHE1 (CCEPR),cervical cancer,qPCR,up-regulated,31364021,,CCEPR,,,,,,,,,,,,
CCHE1 (CCEPR),cervical cancer,qPCR etc.,up-regulated,28239824,,CCEPR,,,,,,,,,,,,
CCHE1 (CCEPR),cervical cancer,"qPCR, RNAi, Western blot, RNA pull-down assay etc.",up-regulated,25921283,,CCEPR,,,,,,,,,,,,
CDKN2B-AS1,cervical cancer,"qPCR, Luciferase reporter assay, Western blot",up-regulated,30884187,,ANRIL,,,,,,,,,,,,
CRNDE,cervical cancer,"qRT-PCR , Luciferase reporter assay , Western blot etc.",up-regulated,31605132,Also Known As: CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180,5,"NR_034105.4, NR_034106.3, NR_110453.2, NR_110454.2, NR_170995.1","5, 9, 5, 9, 9","5, 7, 5, 7, 7","0, 2, 0, 2, 2","0, 0, 0, 0, 0",VALIDATED,"0
5 (2-C-rich, 3-3G)
0
5 (2-C-rich, 3-3G)
5 (2-C-rich, 3-3G)","[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657(3G)] ;

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; 

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; ","The PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have the same G tracts with a left frame shift in G4 hunter.

By looking at all 3 PQS (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

The above situation is same for all the variants","0,0,0,0,0","0,0,0,0,0",No PQS found in G4 hunter
CRNDE,cervical cancer,"qPCR, Western blot, other",up-regulated,30334449,Also Known As: CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180,5,"NR_034105.4, NR_034106.3, NR_110453.2, NR_110454.2, NR_170995.1","5, 9, 5, 9, 9","5, 7, 5, 7, 7","0, 2, 0, 2, 2","0, 0, 0, 0, 0",VALIDATED,"0
5 (2-C-rich, 3-3G)
0
5 (2-C-rich, 3-3G)
5 (2-C-rich, 3-3G)","[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657(3G)] ;

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; 

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; ","The PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have the same G tracts with a left frame shift in G4 hunter.

By looking at all 3 PQS (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

The above situation is same for all the variants","0,0,0,0,0","0,0,0,0,0",No PQS found in G4 hunter
CRNDE,cervical cancer,"qPCR, Western blot, in vitro knockdown, RIP",up-regulated,31202167,Also Known As: CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180,5,"NR_034105.4, NR_034106.3, NR_110453.2, NR_110454.2, NR_170995.1","5, 9, 5, 9, 9","5, 7, 5, 7, 7","0, 2, 0, 2, 2","0, 0, 0, 0, 0",VALIDATED,"0
5 (2-C-rich, 3-3G)
0
5 (2-C-rich, 3-3G)
5 (2-C-rich, 3-3G)","[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657(3G)] ;

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; 

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; ","The PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have the same G tracts with a left frame shift in G4 hunter.

By looking at all 3 PQS (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

The above situation is same for all the variants","0,0,0,0,0","0,0,0,0,0",No PQS found in G4 hunter
CRNDE,cervical cancer,"qPCR, Microarray",up-regulated,29194035,Also Known As: CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180,5,"NR_034105.4, NR_034106.3, NR_110453.2, NR_110454.2, NR_170995.1","5, 9, 5, 9, 9","5, 7, 5, 7, 7","0, 2, 0, 2, 2","0, 0, 0, 0, 0",VALIDATED,"0
5 (2-C-rich, 3-3G)
0
5 (2-C-rich, 3-3G)
5 (2-C-rich, 3-3G)","[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657(3G)] ;

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; 

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; ","The PQS 2 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have the same G tracts with a left frame shift in G4 hunter.

By looking at all 3 PQS (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

The above situation is same for all the variants","0,0,0,0,0","0,0,0,0,0",No PQS found in G4 hunter
DANCR,cervical cancer,"qRT-PCR, Western blot",up-regulated,32123519,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR.Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result.",3,"NR_024031.2, NR_145129.1, NR_145130.1","6,7,7","5,6,6","1,1,1","0,0,0",REVIEWED,"3 (3-C-rich)
1 (C-rich)
1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62(C-rich)] ;

[-0.62(C-rich)]",,"1(C-rich);
1(C-rich);
1(C-rich);

","[-1.444 (C-rich)] ;

[-1.444 (C-rich)] ;

[-1.444 (C-rich)]",No similarity to any PQS  from QGRS mapper
DANCR,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi, other",up-regulated,30362591,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR.Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result.",3,"NR_024031.2, NR_145129.1, NR_145130.1","6,7,7","5,6,6","1,1,1","0,0,0",REVIEWED,"3 (3-C-rich)
1 (C-rich)
1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62(C-rich)] ;

[-0.62(C-rich)]",,"1(C-rich);
1(C-rich);
1(C-rich);

","[-1.444 (C-rich)] ;

[-1.444 (C-rich)] ;

[-1.444 (C-rich)]",No similarity to any PQS  from QGRS mapper
DDN-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, etc.",up-regulated,30582201,Also known as: CAT1507,2,"NR_147178.1, NR_147179.1","18, 16","15, 13","2, 2","1, 1",VALIDATED,"10 (1-4G, 3-3G,1-2G 5-C-rich)
10 (1-4G, 3-3G,1-2G 5-C-rich)","[0.765, 0.873 (4G), 0.9, 0.761 (3G) -0.911, 0.933, -0.894, -0.84, -0.734, -0.86 (C-rich)] ; 

[0.765, 0.873 (4G), 0.9, 0.761 (3G) -0.911, 0.933, -0.894, -0.84, -0.734, -0.86 (C-rich)] ","The 4G PQS of QGRS mapper and the 4G PQS of G4 hunter are the same with the G4 PQS having more nucleotides surrounding the main G4 sequence. 
The PQS 1 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter are the same with a right frame shift in G4 hunter.
The PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter are the same.
By looking at first and second PQS (3G and 4G) from G4 hunter, it appears that at a time only 1 PQS can be formed as both the PQS have few common G-tracts due to overlap amongst them.

The above situation is same for all the variants","0,0","0,0",No PQS found in G4 hunter
DGCR5,cervical cancer,"qPCR, Western blot, etc.",down-regulated,30552671,"Also Known As: DGCR9; DGS-A; DGS-B; DGCR10; LINC00037; POM121L5P; NCRNA00037

2 sequences for DGCR5 (NR_026651.1, NR_024159.1) without any mentioning of transcript variants, while 3 sequences of DGCR5 with clear mentioning of transcipt variants.

PREDICTED REFSEQ (NR_026651.1): This record has not been reviewed and the function is unknown. The reference sequence was derived from BU584104.1, AC000095.5, L77559.1 and BM681417.1.

All transcriprt variants of DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1, NR_026651.1 and NR_024159.1) are reported (Gene Cards - GCID: GC22P019556)

PQS 2 obtained in DGCR5_Variant 2 (NR_045121.1) when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3. Rest two PQS were same in both search parameters.
For further consideration, PQS when search parameter was set to Min G-Group Size: 3 was taken.",3,"DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1)
+
DGCR5 unknown variants (NR_026651.1, NR_024159.1)","32, 32, 11 (DGCR5)
+
7, 28 (DGCR5 unknown variants)","29, 29, 11 (DGCR5)
+
5, 25 (DGCR5 unknown variants)","3, 3, 0 (DGCR5)
+
2, 3 (DGCR5 unknown variants)

","0, 0, 0 (DGCR5)
+
0, 0 (DGCR5 unknown variants)","VALIDATED (DGCR5)

PREDICTED (DGCR5 unknown variant-NR_026651.1)

VALIDATED (DGCR5 unknown variant-NR_024159.1)","12 (4-C-rich, 8-2G);
12 (4-C-rich, 8-2G)
5 (4-C-rich, 1-2G)
","[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[0.911 (2G), -0.894, -0.854, -0.902, -0.933 (C-rich)]",,"0,0,0","0,0,0",No PQS found in G4 hunter
DLEU1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.",up-regulated,30581456,"Also Known As: BCMS; DLB1; LEU1; LEU2; XTP6; BCMS1; DLEU2; LINC00021; NCRNA00021

Some (not checked for PQS) DLEU1-AS1 ""lncRNA"" ncRNA (NR_125753.1) was also there in result.",3,"NR_109973.1, NR_002605.2, NR_109974.1","10,9,8","10,9,8","0,0,0","0,0,0",VALIDATED,"2 (1-2G, 1-C-rich);
2 (1-2G, 1-C-rich);
2 (2G)","[0.774 (2G); -0.804 (C-rich)] ;

[0.774 (2G); -0.804 (C-rich)]; 

[0.744, 1 (2G)] ",,"0,0","0,0",No PQS found in G4 hunter
DLG1-AS1,cervical cancer,"qPCR, other",up-regulated,30231238,,1,NR_038289.1,13,12,0,1,VALIDATED,"2(1-4G, 1-C-rich)","(1.423, -0.935) ",Both the 4G PQS of G4 Hunter and QGRS are same with the G4 PQS having more nucleotides surrounding the main G4 sequence. ,1 (4G),1.683 (4G),Both the 4G PQS of G4 Hunter and QGRS are same with the G4 PQS having more nucleotides surrounding the main G4 sequence. 
DLX6-AS1,cervical cancer,"RT-qPCR, Western blot",up-regulated,32077747,Also Known As: Evf-2; DLX6AS; DLX6-AS; NCRNA00212,1,NR_015448.1,9,9,0,0,VALIDATED,1 (2G),0.854 (2G),No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
DLX6-AS1,cervical cancer,"qPCR, western blot",up-regulated,31539117,Also Known As: Evf-2; DLX6AS; DLX6-AS; NCRNA00212,1,NR_015448.1,9,9,0,0,VALIDATED,1 (2G),0.854 (2G),No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
DLX6-AS1,cervical cancer,"qPCR, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,30535431,Also Known As: Evf-2; DLX6AS; DLX6-AS; NCRNA00212,1,NR_015448.1,9,9,0,0,VALIDATED,1 (2G),0.854 (2G),No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
DSCAM-AS1,cervical cancer,"qRT-PCR, Western blot, RIP",up-regulated,31737900,Also Known As: M41,4,"NR_038896.1, NR_038898.1, NR_038899.1, NR_038900.1","12,7,8,7","12,7,8,7","0,0,0,0","0,0,0,0",VALIDATED,"5 (3-3G, 2-C-rich);
2 (C-rich);
2 (C-rich)
2 (C-rich)","[0.957, 0.911, 1.074 (3G); -0.792, -0.786(C-rich)];

[-0.792, -0.786(C-rich)];

[-0.792, -0.786(C-rich)];

[-0.792, -0.786(C-rich)]",No similarity to any PQS  from QGRS mapper,"0,0,0,0","0,0,0,0",No PQS found in G4 hunter
"FAL1
FALEC",cervical squamous cell carcinoma,"RT-qPCR, Western blot",up-regulated,32046419,Also Known As: FALEC; FAL1; ncRNA-a1; LINC00568,1 (FALEC),NR_051960.1 (FALEC),8 (FALEC),8 (FALEC),0 (FALEC),0 (FALEC),VALIDATED (FALEC),"3 (2-2G, 1-C-rich)","[0.88, 0.851 (2G), -0.921 (C-rich)]",No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
FALEC,cervical cancer,qPCR,up-regulated,31248657,,FAL1,,,,,,,,,,,,
FEZF1-AS1,cervical cancer,qPCR,up-regulated,29917186,,1,NR_036484.1,22,21,1,0,VALIDATED,"11 (6-2G, 5-C-rich)","[0.911, 0.933, 0.898, 1.021, 0.894 (2G); 0.875 -0.755, -0.891, -0.789, -0.913, -1 (C-rich)]",No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
FEZF1-AS1,cervical cancer,qPCR,up-regulated,29917186,,1,NR_036484.1,22,21,1,0,VALIDATED,"11 (6-2G, 5-C-rich)","[0.911, 0.933, 0.898, 1.021, 0.894 (2G); 0.875 -0.755, -0.891, -0.789, -0.913, -1 (C-rich)]",No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
FOXD2-AS1,cervical cancer,"RT-qPCR, Western blot, RIP",up-regulated,32082174,,1,NR_026878.1,24,21,3,0,VALIDATED,10,"[0.891, 0.933, 0.833 (2G) 0.797, 0.98, 0.833, (3G), -0.639, -0.767, -0.907, -0.891 (C-rich)]","The PQS 1 (3G) of QGRS Mapper is similar to PQS 3 (3G) of G4 hunter with a few additional nucleotides surrounding the G4 sequence. 
Similarly, the PQS 2 (3G) of QGRS Mapper is similar to PQS 5 (3G) of G4 hunter with a few additional nucleotides surrounding the G4 sequence. 
There is a slight overlap in PQS 5 and 6 (3G) of G4 hunter.",2 (C-rich),"-1.264, -0.94",No similarity to any PQS  from QGRS mapper
FOXD2-AS1,cervical cancer,qRT-PCR,up-regulated,31841177,,1,NR_026878.1,24,21,3,0,VALIDATED,10,"[0.891, 0.933, 0.833 (2G) 0.797, 0.98, 0.833, (3G), -0.639, -0.767, -0.907, -0.891 (C-rich)]","The PQS 1 (3G) of QGRS Mapper is similar to PQS 3 (3G) of G4 hunter with a few additional nucleotides surrounding the G4 sequence. 
Similarly, the PQS 2 (3G) of QGRS Mapper is similar to PQS 5 (3G) of G4 hunter with a few additional nucleotides surrounding the G4 sequence. 
There is a slight overlap in PQS 5 and 6 (3G) of G4 hunter.",2 (C-rich),"-1.264, -0.94",No similarity to any PQS  from QGRS mapper
FOXP4-AS1,cervical cancer,"qPCR, Luciferase reporter assay etc.",up-regulated,32256085,,3,"NR_126415.1, NR_126416.1, NR_126417.1","2,2,1","2,2,1","0,0,0","0,0,0",VALIDATED,"2 (C-rich), 0, 0","-0.911, -0.959 (C-rich)",No similarity to any PQS  from QGRS mapper,"0,0,0","0,0,0",No PQS found in G4 hunter
GAS5,cervical cancer,"qRT-PCR, Western blot",down-regulated,32105659,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GAS5,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.",down-regulated,30579899,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GAS5,cervical cancer,"qPCR, Western blot",down-regulated,31206689,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GAS5,cervical cancer,"qPCR, RNAi etc.",down-regulated,25400758,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GAS5,cervical cancer,qPCR etc.,up-regulated,22487937,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GAS5,cervical cancer,"qPCR, Western blot, RIP etc.",down-regulated,28671039,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GAS5,cervical cancer,"qPCR, RNAi",down-regulated,29509242,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GAS5-AS1,cervical cancer,"qPCR, Luciferase reporter assay, in vitro knockdown, RIP, etc.",down-regulated,31497208,,1,NR_037605.1,2,2,0,0,VALIDATED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
GATA6-AS,cervical squamous cell carcinoma,"qPCR, Western blot, other",up-regulated,31404324,Also known as: BM742401; locus5689,1,NR_102763.1,14,12,2,0,VALIDATED,"4 (2-C-rich, 2-2G)","['-0.958, -0.885 (C-rich), 0.935, 0.967 (2G)]",No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
GHET1,cervical cancer,qPCR,up-regulated,30948501,Also Known As: ncRNA-GHET1,1,NR_130107.1,10,9,1,0,REVIEWED,"5 (3-C-rich, 1-2G, 1-3G)
","['-0.911, -0.79, -0.959 (C-rich); 0.891, 0.644 (2G); 0.973 (3G)]",The PQS 10 (3G) of QGRS Mapper is similar to PQS 6 (3G) of G4 hunter with a left frame shift in G4 hunter,1,1.413,The PQS 10 (3G) of QGRS Mapper is similar to PQS 1 (3G) of G4 hunter with the same main G4 tracts.
GHET1,cervical cancer,"qRT-PCR, Western blot, RIP",up-regulated,31682716,Also Known As: ncRNA-GHET1,1,NR_130107.1,10,9,1,0,REVIEWED,"5 (3-C-rich, 1-2G, 1-3G)
","['-0.911, -0.79, -0.959 (C-rich); 0.891, 0.644 (2G); 0.973 (3G)]",The PQS 10 (3G) of QGRS Mapper is similar to PQS 6 (3G) of G4 hunter with a left frame shift in G4 hunter,1,1.413,The PQS 10 (3G) of QGRS Mapper is similar to PQS 1 (3G) of G4 hunter with the same main G4 tracts.
GIHCG,cervical cancer,qPCR,up-regulated,30719165,,1,NR_038269.1,4,0,0,0,VALIDATED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
H19,cervical cancer,qPCR,down-regulated,31229557,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008.Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38,37,12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (24 - 2G, 8 - C-rich); 
32 (24 - 2G, 8 - C-rich); 
5 (C-rich)","[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621, (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621 (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)];
 
[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"2; 
2;
0 (3G)","(1.583, 1.37 (3G));

(1.583, 1.37 (3G));",No similarity to any PQS (3G) from QGRS mapper
H19,cervical cancer,"qPCR, RNAi etc.",up-regulated,27633578,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008.Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38,37,12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (24 - 2G, 8 - C-rich); 
32 (24 - 2G, 8 - C-rich); 
5 (C-rich)","[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621, (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621 (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)];
 
[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"2; 
2;
0 (3G)","(1.583, 1.37 (3G));

(1.583, 1.37 (3G));",No similarity to any PQS (3G) from QGRS mapper
H19,cervical cancer,"qPCR, Luciferase Reporter Assay, Western blot.",down-regulated,28797320,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008.Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38,37,12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (24 - 2G, 8 - C-rich); 
32 (24 - 2G, 8 - C-rich); 
5 (C-rich)","[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621, (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621 (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)];
 
[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"2; 
2;
0 (3G)","(1.583, 1.37 (3G));

(1.583, 1.37 (3G));",No similarity to any PQS (3G) from QGRS mapper
H19,cervical cancer,"qPCR, ISH etc.",down-regulated,8570220,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008.Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38,37,12","27,26,11","9,9,1","2,2,0",REVIEWED,"32 (24 - 2G, 8 - C-rich); 
32 (24 - 2G, 8 - C-rich); 
5 (C-rich)","[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621, (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305, 0.837, 0.962, 0.882, 0.891, 0.93, 0.833, 0.934 (2G), -0.911, -0.911, -0.957, -0.621 (C-rich), 0.607, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.824, 0.978, 0.958, 0.891, 0.933, 0.911, 1.061,  0.953 (2G), -0.911, -0.911, -1, -0.8, -0.71 (C-rich)];
 
[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"2; 
2;
0 (3G)","(1.583, 1.37 (3G));

(1.583, 1.37 (3G));",No similarity to any PQS (3G) from QGRS mapper
HAND2-AS1,cervical cancer,"Microarray, qPCR, Western blot, Luciferase reporter assay, RIP etc",down-regulated,32314545,Also Known As: UPH; DEIN; NBLA00301,11,"NR_003679.2, NR_136192.1, NR_136193.1, NR_136194.1, NR_136195.1, NR_136196.1, NR_136197.1, NR_136198.1, NR_136199.1, NR_136200.1, NR_136201.1","1, 19, 22, 21, 11, 5, 19, 18, 20, 22, 24","1, 17, 20, 19, 10, 4, 18, 16, 18, 20, 22","0, 2, 2, 2, 1, 1, 1, 2, 2, 2, 2","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"0;

8 (1 - 2G, 2 - 3G, 5 - C-rich);

10 (1 - 2G, 3 - 3G, 7 - C-rich); 

8 (1 - 2G, 2 - 3G, 5 - C-rich);

1 (3G);

1 (3G);

9 (1 - 2G, 1 - 3G, 7 - C-rich);

8 (1 - 2G, 2 - 3G, 5 - C-rich));

8 (1 - 2G, 2 - 3G, 5 - C-rich);

10 (1 - 2G, 3 - 3G, 7 - C-rich); 

10 (1 - 2G, 3 - 3G, 7 - C-rich)","0;

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654 (3G)];

[0.654 (3G)];

[-0.905, -0.911, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G), 0.913 (3G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)]","In variant 2, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variant 3, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 16 (3G) of QGRS mapper and the PQS 9 (3G) of G4 hunter have similar G tracts.

PQS 9 (3G) from G4 hunter has a left frame-shift as compared to PQS 16 (3G) from QGRS mapper.

In variant 4, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 5 and 6, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

In variant 7, PQS 13 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

PQS 8 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 8 and 9, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 10 and 11, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 16 (3G) of QGRS mapper and the PQS 9 (3G) of G4 hunter have similar G tracts.

PQS 9 (3G) from G4 hunter has a left frame-shift as compared to PQS 16 (3G) from QGRS mapper.","0; 

3 (3G);

3 (3G);

3 (3G);

0;

0;

3 (3G);

3 (3G);

3 (3G);

3 (3G);

3 (3G)","0;

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

0;

0;

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)]","In variants 2, 3, 4, 7, 8, 9, 10 and 11, PQS 13 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

By looking at PQS 1, 2 and 3 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. "
HAND2-AS1,cervical squamous cell carcinoma,"qPCR, western blot",down-regulated,31555362,Also Known As: UPH; DEIN; NBLA00301,11,"NR_003679.2, NR_136192.1, NR_136193.1, NR_136194.1, NR_136195.1, NR_136196.1, NR_136197.1, NR_136198.1, NR_136199.1, NR_136200.1, NR_136201.1","1, 19, 22, 21, 11, 5, 19, 18, 20, 22, 24","1, 17, 20, 19, 10, 4, 18, 16, 18, 20, 22","0, 2, 2, 2, 1, 1, 1, 2, 2, 2, 2","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"0;

8 (1 - 2G, 2 - 3G, 5 - C-rich);

10 (1 - 2G, 3 - 3G, 7 - C-rich); 

8 (1 - 2G, 2 - 3G, 5 - C-rich);

1 (3G);

1 (3G);

9 (1 - 2G, 1 - 3G, 7 - C-rich);

8 (1 - 2G, 2 - 3G, 5 - C-rich));

8 (1 - 2G, 2 - 3G, 5 - C-rich);

10 (1 - 2G, 3 - 3G, 7 - C-rich); 

10 (1 - 2G, 3 - 3G, 7 - C-rich)","0;

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654 (3G)];

[0.654 (3G)];

[-0.905, -0.911, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G), 0.913 (3G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)]","In variant 2, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variant 3, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 16 (3G) of QGRS mapper and the PQS 9 (3G) of G4 hunter have similar G tracts.

PQS 9 (3G) from G4 hunter has a left frame-shift as compared to PQS 16 (3G) from QGRS mapper.

In variant 4, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 5 and 6, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

In variant 7, PQS 13 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

PQS 8 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 8 and 9, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 10 and 11, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 16 (3G) of QGRS mapper and the PQS 9 (3G) of G4 hunter have similar G tracts.

PQS 9 (3G) from G4 hunter has a left frame-shift as compared to PQS 16 (3G) from QGRS mapper.","0; 

3 (3G);

3 (3G);

3 (3G);

0;

0;

3 (3G);

3 (3G);

3 (3G);

3 (3G);

3 (3G)","0;

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

0;

0;

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)]","In variants 2, 3, 4, 7, 8, 9, 10 and 11, PQS 13 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

By looking at PQS 1, 2 and 3 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. "
HAND2-AS1,cervical cancer,"Microarray, Dual luciferase reporter assay, RIP, RT-qPCR, Western blot analysis",down-regulated,31889905,Also Known As: UPH; DEIN; NBLA00301,11,"NR_003679.2, NR_136192.1, NR_136193.1, NR_136194.1, NR_136195.1, NR_136196.1, NR_136197.1, NR_136198.1, NR_136199.1, NR_136200.1, NR_136201.1","1, 19, 22, 21, 11, 5, 19, 18, 20, 22, 24","1, 17, 20, 19, 10, 4, 18, 16, 18, 20, 22","0, 2, 2, 2, 1, 1, 1, 2, 2, 2, 2","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"0;

8 (1 - 2G, 2 - 3G, 5 - C-rich);

10 (1 - 2G, 3 - 3G, 7 - C-rich); 

8 (1 - 2G, 2 - 3G, 5 - C-rich);

1 (3G);

1 (3G);

9 (1 - 2G, 1 - 3G, 7 - C-rich);

8 (1 - 2G, 2 - 3G, 5 - C-rich));

8 (1 - 2G, 2 - 3G, 5 - C-rich);

10 (1 - 2G, 3 - 3G, 7 - C-rich); 

10 (1 - 2G, 3 - 3G, 7 - C-rich)","0;

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654 (3G)];

[0.654 (3G)];

[-0.905, -0.911, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G), 0.913 (3G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913  (3G), -0.938, -0.827, -0.872, -0.958, -0.649  (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)];

[0.654, 0.913 (3G), -0.684, -0.851, -0.938, -0.827, -0.872, -0.958, -0.649 (C-rich), 1 (2G)]","In variant 2, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variant 3, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 16 (3G) of QGRS mapper and the PQS 9 (3G) of G4 hunter have similar G tracts.

PQS 9 (3G) from G4 hunter has a left frame-shift as compared to PQS 16 (3G) from QGRS mapper.

In variant 4, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 5 and 6, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

In variant 7, PQS 13 (3G) of QGRS mapper and the PQS 8 (3G) of G4 hunter have similar G tracts.

PQS 8 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 8 and 9, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 7 (3G) of G4 hunter have similar G tracts.

PQS 7 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

In variants 10 and 11, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 16 (3G) of QGRS mapper and the PQS 9 (3G) of G4 hunter have similar G tracts.

PQS 9 (3G) from G4 hunter has a left frame-shift as compared to PQS 16 (3G) from QGRS mapper.","0; 

3 (3G);

3 (3G);

3 (3G);

0;

0;

3 (3G);

3 (3G);

3 (3G);

3 (3G);

3 (3G)","0;

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

0;

0;

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)];

[1.422, 1.457, 1.266 (3G)]","In variants 2, 3, 4, 7, 8, 9, 10 and 11, PQS 13 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

PQS 13 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 13 (3G) from QGRS mapper.

By looking at PQS 1, 2 and 3 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. "
HCP5,cervical cancer,"qPCR, Western blot, Luciferase Reporter Gene Assay",up-regulated,30070314,"Also Known As: P5-1; 6S2650E; D6S2650E
",1,NR_040662.1,23,21,2,0,VALIDATED,"2 (1 - 2G, 1 - C-rich)","[0.913 (2G), -0.857 (C-rich)]",,0,0,No PQS found in G4 hunter
HIPK1-AS,cervical cancer,"Microarray, qPCR, in vitro knockdown",up-regulated,29901171,,2,"NR_110725.1, NR_110726.1","17, 6","17,6","0,0","0,0",VALIDATED,"1 (2G) 
1 (2G) 
","[0.83, 0.891 (2G)];

[0.83, 0.891 (2G)]

",,0,0,No PQS found in G4 hunter
HNF1A-AS1,cervical cancer,"Dual luciferase reporter gene assay, RIP, RT-qPCR, Western blot assay",up-regulated,31827397,Also Known As: HAS1; C12orf27; NCRNA00262,1,NR_024345.1,15,15,0,0,VALIDATED,4 (C-rich);,"[-0.933, -0.808, -0.911, -0.792 (C-rich)]",,0,0,No PQS found in G4 hunter
HOTAIR,cervical cancer,RNA-seq,up-regulated,30981759,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,qPCR,up-regulated,30134241,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, other",up-regulated,30367473,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, other",,30275757,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,qPCR etc.,up-regulated,25366139,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,qPCR etc.,up-regulated,29620291,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, RNAi, Western blot, Flow cytometry assay etc.",up-regulated,26962687,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot etc.",up-regulated,29572071,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, RNAi, Western blot etc.",up-regulated,27323817,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot etc.",up-regulated,26523512,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, ELISA etc.",up-regulated,27184657,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,qPCR etc.,differential expression,27229487,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, RNAi, Cell proliferation assay, Cell invasion assay etc.",up-regulated,25762744,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,qPCR etc.,up-regulated,24748337,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,qPCR etc.,down-regulated,22487937,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot, Luciferase Reporter Assay",differential expression,28893349,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot, RNAi etc",down-regulated,29130509,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc.",up-regulated,29336659,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29335299,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Luciferase Assay etc.",up-regulated,29163829,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, RNAi, Western blot etc.",up-regulated,27574106,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"Microarray, qPCR, Western blot, Luciferase reporter assay, RNAi",up-regulated,29391067,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Luciferase reporter assay etc.",up-regulated,27467165,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Luciferase reporter assay etc.",down-regulated,27683269,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"Microarray, qPCR, RIP etc.",down-regulated,26152361,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, Western blot etc.",differential expression,25547435,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOTAIR,cervical cancer,"qPCR, RNAi, Western blot etc.",up-regulated,25405331,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072. Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18,17,16","17,16,15","1,1,1","0,0,0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

"
HOXA11-AS,cervical cancer,"qPCR, RNAi, Western blot, Cell proliferation assay etc.",up-regulated,27792998,Also Known As: HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076,1,NR_002795.2,18,16,2,0,REVIEWED,"12 (7 - 2G, 5 - C-rich)","[0.857, 0.833, 0.737, 0.911, 0.918, 0.87, 1.064 (2G), -0.642, -0.638, -0.911, -0.957, -0.831 (C-rich)] ",,0,0,No PQS found in G4 Hunter
HOXD-AS1 (HAGLR),cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29896986,Also Known As: Mdgt; HOXD-AS1; MIR7704HG,12,"NR_110458.1, NR_110459.1, NR_110460.1, NR_110461.1, NR_110462.1, NR_110463.1, NR_110464.1, NR_110465.1, NR_110466.1, NR_033979.2, NR_110467.1, NR_110468.1","27, 25, 25, 23, 27, 25, 25, 23, 23, 22, 24, 24","25, 23, 23, 22, 25, 24, 24, 21, 21, 20, 23, 23","2, 2, 2, 1, 2, 1, 1, 2, 2, 2, 1, 1

PQS 1 of 1st and 5th variants is same.
PQS 1 of 2nd variant is same to the PQS 1 of 3rd, 8th and 9th variants.
PQS 1 of 10th variant is different from all other variants. 
PQS 2 of 1st variant is same to the PQS 1 of 4th, 6th, 7th, 11th and 12th variants; and same to the PQS 2 of 2nd, 3rd, 5th, 8th, 9th and 10th variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"18 (5 - 2G, 2 - 3G, 11 - C-rich);

22 (5 - 2G, 3 - 3G, 14 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

18 (5 - 2G, 2 - 3G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

20 (2 - 2G, 2 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich)","[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G), 0.763, 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891,  -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864,  -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1 (3G), 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)]","In variants 1 and 5, PQS 4 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

In variant 2, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variants 3 and 8, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variant 9, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.","3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich)","[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper.
HOXD-AS1 (HAGLR),cervical cancer,"qPCR, Western blot etc.",up-regulated,29228418,Also Known As: Mdgt; HOXD-AS1; MIR7704HG,12,"NR_110458.1, NR_110459.1, NR_110460.1, NR_110461.1, NR_110462.1, NR_110463.1, NR_110464.1, NR_110465.1, NR_110466.1, NR_033979.2, NR_110467.1, NR_110468.1","27, 25, 25, 23, 27, 25, 25, 23, 23, 22, 24, 24","25, 23, 23, 22, 25, 24, 24, 21, 21, 20, 23, 23","2, 2, 2, 1, 2, 1, 1, 2, 2, 2, 1, 1

PQS 1 of 1st and 5th variants is same.
PQS 1 of 2nd variant is same to the PQS 1 of 3rd, 8th and 9th variants.
PQS 1 of 10th variant is different from all other variants. 
PQS 2 of 1st variant is same to the PQS 1 of 4th, 6th, 7th, 11th and 12th variants; and same to the PQS 2 of 2nd, 3rd, 5th, 8th, 9th and 10th variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"18 (5 - 2G, 2 - 3G, 11 - C-rich);

22 (5 - 2G, 3 - 3G, 14 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

18 (5 - 2G, 2 - 3G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

20 (2 - 2G, 2 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich)","[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G), 0.763, 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891,  -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864,  -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1 (3G), 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)]","In variants 1 and 5, PQS 4 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

In variant 2, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variants 3 and 8, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variant 9, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.","3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich)","[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper.
HOXD-AS1 (HAGLR),cervical cancer,"qPCR, Western blot, Dual luciferase reporter assay, etc.",up-regulated,29896986,Also Known As: Mdgt; HOXD-AS1; MIR7704HG,12,"NR_110458.1, NR_110459.1, NR_110460.1, NR_110461.1, NR_110462.1, NR_110463.1, NR_110464.1, NR_110465.1, NR_110466.1, NR_033979.2, NR_110467.1, NR_110468.1","27, 25, 25, 23, 27, 25, 25, 23, 23, 22, 24, 24","25, 23, 23, 22, 25, 24, 24, 21, 21, 20, 23, 23","2, 2, 2, 1, 2, 1, 1, 2, 2, 2, 1, 1

PQS 1 of 1st and 5th variants is same.
PQS 1 of 2nd variant is same to the PQS 1 of 3rd, 8th and 9th variants.
PQS 1 of 10th variant is different from all other variants. 
PQS 2 of 1st variant is same to the PQS 1 of 4th, 6th, 7th, 11th and 12th variants; and same to the PQS 2 of 2nd, 3rd, 5th, 8th, 9th and 10th variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"18 (5 - 2G, 2 - 3G, 11 - C-rich);

22 (5 - 2G, 3 - 3G, 14 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

18 (5 - 2G, 2 - 3G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

20 (2 - 2G, 2 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich)","[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G), 0.763, 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891,  -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864,  -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1 (3G), 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)]","In variants 1 and 5, PQS 4 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

In variant 2, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variants 3 and 8, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variant 9, PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.","3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich)","[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper.
HULC,cervical cancer,"qRT-PCR, Western blot",up-regulated,32103980,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter
HULC,cervical cancer,qPCR etc.,up-regulated,27775802,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter
LINC-POU3F3 PANTRI1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,31252264,Also Known As: PANTRI1; LINC01158; linc-Brn1a; linc-POU3F3,4 (PANTRI1),"PANTRI1 (NR_037883.1, NR_131233.1, NR_131234.1, NR_131235.1)","13, 5, 5, 6 (PANTRI1)","12, 5, 5, 6 (PANTRI1)","1, 0, 0, 0 (PANTRI1)","0, 0, 0, 0 (PANTRI1)",VALIDATED (PANTRI1),"2 (1 - 2G, 1 - C-rich)

0;

1 (C-rich);

1 (C-rich)","[-0.616 (C-rich), 0.768 (2G)]; 

0;

[-0.616 (C-rich)];

[-0.616 (C-rich)]",,0,0,No PQS found in G4 Hunter
LINC-ROR,cervical cancer,qPCR etc.,up-regulated,26314857,"Also Known As: ROR; lincRNA-RoR; lincRNA-ST8SIA3. Some (older) transcribed RNA, LINC-ROR variants (2-14; variant 1 not available in NCBI-NT) ""other"" ncRNA (complete sequence - _____, AB844430.1, AB844431.1, AB844432.1, AB844433.1, AB908956.1, AB932951.1, LC027885.1, LC027886.1, LC027887.1, LC027888.1, LC027889.1, LC027890.1 and LC027884.1 respectively) with PQS-___, 3, 1, 0, 0, 4, 1, 4, 13, 7, 8, 7, 2, 2 respectively were also there in result.",2,"NR_048536.2, NR_152602.1","15,13","15,13","0,0","0,0",REVIEWED,"3 (C-rich);

3 (C-rich)","[-0.933, -0.891, -0.911 (C-rich)];

[-0.933, -0.891, -0.911 (C-rich)]",,0,0,No PQS found in G4 Hunter
LINC-UFC1 (LOC112543491),cervical cancer,"qPCR, western blot, RIP etc.",up-regulated,29790665,,1,NR_156734.1,20,20,0,0,VALIDATED,1 (C-rich),[-0.789 (C-rich)],"No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter
LINC-UFC1 (LOC112543491),cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,29790665,,1,NR_156734.1,20,20,0,0,VALIDATED,1 (C-rich),[-0.789 (C-rich)],"No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter
LINC00037,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.",down-regulated,30613967,,Refer to DGCR5,,,,,,,"12 (4-C-rich, 8-2G);
12 (4-C-rich, 8-2G)
5 (4-C-rich, 1-2G)
","[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[0.911 (2G), -0.894, -0.854, -0.902, -0.933 (C-rich)]",,"0,0,0","0,0,0",No PQS found in G4 hunter
LINC00052,cervical cancer,"qPCR, Western blot",down-regulated,31210293,Also known as: TMEM83; NCRNA00052,1,NR_026869.1,5,5,0,0,VALIDATED,"3 (2-C-rich, 1-2G)","['-0.841, -1.02 (C-rich) 0.707 (2G)]",,0,0,No PQS found in G4 hunter
LINC00152 CYTOR,cervical cancer,"qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc.",up-regulated,31114990,Also Known As: C2orf59; LINC00152; NCRNA00152; CYTOR,5 (CYTOR),"NR_024204.2, NR_024205.3, NR_024206.2, NR_146460.1, NR_146461.1    (CYTOR)         ","4, 6, 4, 4, 3 (CYTOR)","4, 6, 4, 4, 3 (CYTOR)","0,0,0,0,0 (CYTOR)","0,0,0,0,0 (CYTOR)",REVIEWED (CYTOR),"2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);","[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)]",,0,0,No PQS found in G4 Hunter
LINC00152 CYTOR,cervical cancer,"western blot, in vitro konckdown",up-regulated,28536419,Also Known As: C2orf59; LINC00152; NCRNA00152; CYTOR,5 (CYTOR),"NR_024204.2, NR_024205.3, NR_024206.2, NR_146460.1, NR_146461.1    (CYTOR)         ","4, 6, 4, 4, 3 (CYTOR)","4, 6, 4, 4, 3 (CYTOR)","0,0,0,0,0 (CYTOR)","0,0,0,0,0 (CYTOR)",REVIEWED (CYTOR),"2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);

2 (C-rich);","[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)];

[-0.978, -0.75 (C-rich)]",,0,0,No PQS found in G4 Hunter
LINC00277 EWSAT1,cervical cancer,"Microarray analysis, qRT-PCR, Western blot, RNAi",down-regulated,28767188,Also Known As: TMEM84; LINC00277; NCRNA00277; EWSAT1,1 (EWSAT1),EWSAT1 (NR_026949.1),15 (EWSAT1),14 (EWSAT1),1 (EWSAT1),0 (EWSAT1),VALIDATED (EWSAT1),"15 (4 -2G, 13- C rich)
","[0.894, 0.894, 0.813, 0.911 (2G); -0.913, -1, -0.854, -0.646, -0.894, -0.915, -0.911, -0.984, -0.93, -0.979, -0.894, -0.933 (C-rich)]",,0,0,No PQS found in G4 hunter
LINC00319,cervical cancer,"qRT-PCR, Western blot, Luciferase reporter assays, RIP",up-regulated,31942724,Also known as: PRED49; C21orf125; NCRNA00319,1,NR_152722.1,30,30,0,0,VALIDATED,"19 (18-C-rich, 1-2G)","['-0.891, -1.021, -0.911, -0.86, -0.894, -0.88, -0.86, -0.946, -0.922, -1.021, -0.825, -0.722, -1.043, -0.899, -0.888, -0.92 , -1.043, -0.81 (C-rich); 0.83 (2G)]",,1 (C-rich),-1.169,No similarity to any PQS  from QGRS mapper
LINC00473,cervical cancer,"qPCR, Western blotting etc.",up-regulated,29218240,Also Known As: LNC473; C6orf176; bA142J11.1,2,"NR_026860.1, NR_026861.1","12,5","12,5","0,0","0,0",VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter
LINC00511,cervical cancer,"RT-qPCR, Western blot, Microarray",up-regulated,32067228,Also Known As: LCAL5; onco-lncRNA-12,1,NR_033876.1,18,16,2,0,VALIDATED,"7 (6 - 2G, 1 - C-rich)","[1, 0.878, 0.891, 0.911, 0.531, 0.855 (2G), -0.864 (C-rich)] 
",,0,0,No PQS found in G4 Hunter
LINC00511,cervical cancer,"RT-qPCR, in vitro knockdown, Western blot etc.",up-regulated,31180057,Also Known As: LCAL5; onco-lncRNA-12,1,NR_033876.1,18,16,2,0,VALIDATED,"7 (6 - 2G, 1 - C-rich)","[1, 0.878, 0.891, 0.911, 0.531, 0.855 (2G), -0.864 (C-rich)] 
",,0,0,No PQS found in G4 Hunter
LINC00511,cervical cancer,"qPCR, other",up-regulated,31434692,Also Known As: LCAL5; onco-lncRNA-12,1,NR_033876.1,18,16,2,0,VALIDATED,"7 (6 - 2G, 1 - C-rich)","[1, 0.878, 0.891, 0.911, 0.531, 0.855 (2G), -0.864 (C-rich)] 
",,0,0,No PQS found in G4 Hunter
LINC00518,cervical cancer,"qPCR, Western blot",up-regulated,30720156,Also known as: C6orf218,1,NR_027793.1,8,8,0,0,VALIDATED,2 (C-rich) ,"['-0.771, -0.814 (C-rich)]",No similarity to any PQS  from QGRS mapper,0,0,No PQS found in G4 hunter
LINC00958 BLACAT2,cervical cancer,"RT-qPCR, Luciferase reporter assay, RIP, Western blot analysis",up-regulated,31691355,"Also Known As: BLACAT2: LINC00958. Some (older) bladder associated transcript 2 variant 1, 2 and 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MF435912.1, MF435913.1 and MF435914.1 respectively) with PQS- 4, 4, 5 respectively, were also there in result.",1 (BLACAT2),BLACAT2 (NR_038904.1),10 (BLACAT2),10 (BLACAT2),0 (BLACAT2),0 (BLACAT2),VALIDATED (BLACAT2),,,,,,
LINC00958 BLACAT2,cervical cancer,"Luciferase reporter assay , Western blot etc.",up-regulated,31169309,"Also Known As: BLACAT2: LINC00958. Some (older) bladder associated transcript 2 variant 1, 2 and 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MF435912.1, MF435913.1 and MF435914.1 respectively) with PQS- 4, 4, 5 respectively, were also there in result.",1 (BLACAT2),BLACAT2 (NR_038904.1),10 (BLACAT2),10 (BLACAT2),0 (BLACAT2),0 (BLACAT2),VALIDATED (BLACAT2),,,,,,
LINC01101,cervical cancer,"Microarray analysis, qRT-PCR, Western blot, RNAi",down-regulated,28767188,,1,NR_027181.1,24,24,0,0,VALIDATED,"3 (2-C-rich, 1-2G)","[-0.933, -0.888 (C-rich); 
0.911 (2G)]",,0,0,No PQS found in G4 hunter
LINC01133,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP",up-regulated,31390932,,1,NR_038849.1,7,7,0,0,VALIDATED,2 (C-rich),"[-0.803, -0.701 (C-rich)]",,0,0,No PQS found in G4 Hunter
LINC01139,cervical cancer,"Microarray, qPCR etc.",differential expression,27035672,Also known as: LINKA; LINK-A,1,NR_015407.1,8,8,0,0,VALIDATED,"4 (3-C-rich, 1-2G)","[-1.021, -0.913, -0.882 
(C-rich); 0.73 (2G)]",,0,0,No PQS found in G4 hunter
LINC01305,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP, etc.",up-regulated,30697971,,1,NR_038897.1,28,23,5,0,VALIDATED,21,"-0.852, -0.94, -0.947, 
0.815, 1, -0.603, 0.821, 
-0.933, -0.915, -1.143,
 -0.722, 0.978, 0.911, 
0.868, 0.917, 1.124, 
-0.933, -0.738, 0.779,
 0.759",,8,"-1.491, -1.286, 1.253, 
1.413, 1.391, 1.24,
 1.422, 1.34",
LINC01503,cervical cancer,"Microarray, qPCR etc.",differential expression,27035672,,2,"NR_120685.1, NR_120686.1","6,6","5,5","1,1","0,0",VALIDATED,"9 (1 - 2G, 4 - 3G, 4 - C-rich);

9 (1 - 2G, 4 - 3G, 4 - C-rich)","[0.911, 0.88, 0.911, 0.933 (3G), 0.833 (2G), -0.814, -1.096, -0.911, -0.837 (C-rich)];

[0.911, 0.88, 0.911, 0.933 (3G), 0.833 (2G), -0.814, -1.096, -0.911, -0.837 (C-rich)]","In variants 1 and 2, PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

By looking at PQS 1, 2, 3 and 4 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",0,0,No PQS found in G4 Hunter
LINC01535,cervical cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,31273925,,3,"NR_110718.1,NR_110719.1,NR_110720.2","17,5,6","17,5,6","0,0,0","0,0,0",VALIDATED,"0
1 (C-rich)
3 (C-rich)
","
[-0.767 (C-rich)];

[-0.911, -0.93, -0.767 
(C-rich)]



",,0,0,No PQS found in G4 hunter
LINC01783,cervical cancer,"qRT-PCR, RIP",up-regulated,32021449,,1,NR_135764.1,16,14,2,0,VALIDATED,"6 (1-C-rich, 2-2G, 3-3G)","[-0.958 (C-rich), 0.69, 0.891, 0.952 (3G)
0.878, 0.843 (2G)]","The PQS 1 (3G) of QGRS 
Mapper is similar to PQS 
1 (3G) of G4 hunter with 
a few additional nucleotides 
surrounding the G4 sequence. 

Similarly, the PQS 2 (3G) 
of QGRS Mapper is similar to PQS 2 (3G) of G4 hunter with a few additional nucleotides 
surrounding the G4 sequence. ",0,0,No PQS found in G4 hunter
LINP1,cervical cancer,"qPCR, Western blot, RIP etc.",up-regulated,32348690,,1,NR_138480.1,7,5,2,0,VALIDATED,"4 (1 - 2G, 3 - C-rich)","[-0.915, -0.911, -0.847 (C-rich), 0.808 (2G)] 
","PQS 6 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.
",1 (3G),[1.4 (3G)],"PQS 6 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
"
LINP1,cervical cancer,"qPCR, RIP",up-regulated,29527968,,1,NR_138480.1,7,5,2,0,VALIDATED,"4 (1 - 2G, 3 - C-rich)","[-0.915, -0.911, -0.847 (C-rich), 0.808 (2G)] 
","PQS 6 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.
",1 (3G),[1.4 (3G)],"PQS 6 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.
"
lnc-LIF-AS,cervical cancer,"RT-PCR , Western blot etc.",up-regulated,31085454,Also known as: Lnc-LIF-AS,1,NR_149070.1,7,7,0,0,VALIDATED,6 (C-rich),"[-0.895, -1.02, -0.933, -0.957, -0.896, -0.793
(C-rich)]",,0,0,No PQS found in G4 hunter
lncRNA-ATB,cervical cancer,"qPCR, Luciferase reporter assay, Western blot",up-regulated,30908730,,1,NR_160525.1,17,16,1,0,VALIDATED,"4 (1 - 2G, 3 - C-rich)","[-0.87, -0.913, -0.917 (C-rich), 0.729 (2G)]  
","No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter
lncRNA-ATB,cervical cancer,qPCR,up-regulated,29237907,,1,NR_160525.1,17,16,1,0,VALIDATED,"4 (1 - 2G, 3 - C-rich)","[-0.87, -0.913, -0.917 (C-rich), 0.729 (2G)]  
","No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter
lncRNA-CTS,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.",up-regulated,31499118,Also known as: SH3PXD2A-AS1,1,NR_038940.1,10,10,0,0,VALIDATED,"3 (2-C-rich, 1-2G)","[-0.911, -0.903 (C-rich);
0.933 (2G)]",,0,0,No PQS found in G4 hunter
lncRNA-LET,cervical cancer,qPCR etc.,down-regulated,25755778,Also known as: NPTN-IT1,1,NR_103844.1,13,13,0,0,VALIDATED,"11 (3 - 2G, 9 - C-rich)","[-0.647, -0.913, -0.911, -0.913, -0.933, -0.872, -0.783, -0.852 (C-rich), 0.935, 0.935, 0.911, 0.935 (2G)]
",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
lncRNA-MIF ODC1-DT       ,cervical cancer,"qPCR, Luciferase reporter assay etc.",differential expression,27317567,Also Known As: ODC1-DT; (ODC1-DT),1 (ODC1-DT),ODC1-DT (NR_110597.1),6 (ODC1-DT),6 (ODC1-DT),0 (ODC1-DT),0 (ODC1-DT),VALIDATED (ODC1-DT),0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
lncRNA-NEF,cervical squamous cell carcinoma,"qPCR, Western blot",down-regulated,30910843,"Also known as: LINC01384; lncRNA-NEF, LNCNEF",1,NR_109883.1,4,4,0,0,VALIDATED,1 (C-rich),[-0.913 (C-rich)],,0,0,No PQS found in G4 hunter
lncRNA-SRA1 LINC00673,cervical squamous cell carcinoma,qPCR,down-regulated,31371629,Also Known As: lncRNA00673; LINC00673 [mentioned in qRT-PCR primers table in paper for lncRNA00673 (PubMed-29077173)]; SLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75,5 (LINC00673),"LINC00673 (NR_137281.2, NR_137280.2, NR_036488.1, NR_152515.1, NR_152516.1)","26, 25, 23, 23, 27 (LINC00673)","24, 23, 22, 22, 25 (LINC00673)","2, 2, 1, 1, 2 (LINC00673)","0, 0, 0, 0, 0 (LINC00673)",REVIEWED (LINC00673),"9 (2 - 2G, 2 - 3G, 5 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich)","[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];
 
(1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

(1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)]","In variants 1, 2 and 5, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

In variants 3 and 4, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 hunter
loc285194 TUSC7,cervical squamous cell carcinoma,"qPCR, Western blot etc",up-regulated,31774069,"Also Known As: LOC285194; TUSC7; LSAMPAS3; LINC00902; LSAMP-AS1; LSAMP-AS3; NCRNA00295. LOC285194 mentioned in title of papers [PubMed-31494574 (TUSC7) and 27683121 (RPL34-DT)] referred in TUSC7 (NR_015391.1) and RPL34-DT (NR_026968.1). Aliases for TUSC7 Gene (From GeneCards database - GCID: GC03P116709)
Tumor Suppressor Candidate 7
TUSC7",1 (TUSC7),TUSC7 (NR_015391.1),9 (TUSC7),9 (TUSC7),0 (TUSC7),0 (TUSC7),VALIDATED (TUSC7),4 (2G),"[0.911, 0.776, 0.935, 0.891  (2G)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
LOC554202 (MIR31HG),cervical cancer,"qPCR, Western blot etc.",up-regulated,29129878,"Also Known As: LOC554202; MIR31HG; LncHIFCAR; hsa-lnc-31.LOC554202 mentioned in title of paper (PubMed-22289355 and others) referred in MIR31HG_variants (NR_027054.2, NR_152877.1, NR_152878.1, NR_152879.1).Aliases for MIR31HG Gene (From GeneCards database - GCID: GC09M021439)
MIR31 Host Gene",4 (MIR31HG),"MIR31HG (NR_027054.2, NR_152877.1, NR_152878.1, NR_152879.1)","20, 13, 12, 19 (MIR31HG)","19, 13, 12, 18 (MIR31HG)","1, 0, 0, 1 (MIR31HG)","0, 0, 0, 0 (MIR31HG)",REVIEWED (MIR31HG),"7 (2 - 2G, 5 - C-rich);
5 ( C-rich);
4 (C-rich);
6 (1 - 2G, 5 - C-rich);","[1.034, 0.94 (2G); -0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];
[-0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)];
[-0.9, -0.789, -0.911, -0.936 (C-rich)];
[1.034, 0.94 (2G); -0.9, -0.789, -0.911, -0.936 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
LUCAT1,cervical cancer,"qPCR, Western blot, RIP, Luciferase reporter assay etc",up-regulated,32207530,Also Known As: SCAL1; SCAT5,2,"NR_103548.1, NR_103549.1","3,2","3,2","0,0","0,0",VALIDATED,"0;
3 (2G)","0;
[0.876, 0.911, 0.911 (2G)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
LUCAT1,cervical cancer,"qPCR, RNA-seq",up-regulated,30831032,Also Known As: SCAL1; SCAT5,2,"NR_103548.1, NR_103549.1","3,2","3,2","0,0","0,0",VALIDATED,"0;
3 (2G)","0;
[0.876, 0.911, 0.911 (2G)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
LUCAT1,cervical cancer,"qPCR, Western blot, etc.",up-regulated,31486481,Also Known As: SCAL1; SCAT5,2,"NR_103548.1, NR_103549.1","3,2","3,2","0,0","0,0",VALIDATED,"0;
3 (2G)","0;
[0.876, 0.911, 0.911 (2G)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
MAGI2-AS3,cervical squamous cell carcinoma,"qPCR, Western blot",up-regulated,31832086,,4,"NR_038343.2, NR_038344.1, NR_038345.1, NR_038346.1","22, 9, 2, 3","21, 8, 2, 3","1, 1, 0, 0","0, 0, 0, 0",VALIDATED,"7 (1-C-rich, 2-3G, 4-2G)
3 (2-3G, 1-2G)
0
0","[-0.894 (C-rich), 0.691, 1 (3G) 0.683, 0.894, 0.8, 0.789(2G)];

[0.691, 1 (3G), 0.683 (2G)]","The PQS 1 (3G) of QGRS
Mapper and PQS 1 (3G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.
By looking at both PQS (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

The situation is similar for
the second variant.",0,0,No PQS found in G4 Hunter
MALAT1,cervical cancer,"qRT-PCR, Western blot",up-regulated,32152961,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"RT-PCR, western-blot",up-regulated,32113834,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, Luciferase reporter assay,",up-regulated,30178834,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, etc.",up-regulated,30633360,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, RNAi, Western blot, MTT assay etc.",up-regulated,28252165,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, Cell transfection, Western blot, Dual luciferase reporter assay, Flow cytometry assay etc.",differential expression,27658300,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, RNAi, RIP, Flow cytometry assay, RNA pull-down assay etc.",up-regulated,26311052,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, RNAi, Western blot, Luciferase reporter assay, Flow cytometry assay etc.",up-regulated,26242259,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, Western blot etc.",down-regulated,29704494,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, RNAi, Western blot, Dual luciferase reporter assay etc.",down-regulated,25773124,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, ELISA etc.",up-regulated,27184657,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,qPCR etc.,down-regulated,22487937,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,qPCR etc.,up-regulated,20213048,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, Northern blot etc.",differential expression,22491206,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, RNAi, Western blot etc.",up-regulated,26798987,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, RNAi, Luciferase reporter assay, MTT assay etc.",up-regulated,26400521,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,"qPCR, Cell proliferation assay etc.",up-regulated,26854446,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MALAT1,cervical cancer,qPCR etc.,up-regulated,24932303,Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047,3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
","2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants,
 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
"
MCM3AP-AS1,cervical squamous cell carcinoma,RT-qPCR,down-regulated,31985002,Also known as: C21orf85; MCM3APAS; MCM3AP-AS; MCM3APASB; NCRNA00031,4,"NR_110565.1, NR_002776.4,NR_110566.1,NR_110567.1","9,9,10,11","9,9,10,11","0,0,0,0","0,0,0,0",VALIDATED,"2 (C-rich);
1 (C-rich);
0
3 (2G)","[-0.829, -0.911 (C-rich)]

[-0.911 (C-rich)];

[0.855, 0.933, 0.911 ()]",,,,
MEG3,cervical cancer,qPCR,down-regulated,30174437,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP",down-regulated,31320837,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,qPCR etc.,down-regulated,28787698,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,"qPCR, ELISA etc.",down-regulated,27184657,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,qPCR etc.,up-regulated,22487937,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,"qPCR, ISH etc.",down-regulated,14602737,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,"qPCR, RNAi, Western blot etc.",down-regulated,26574780,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,"qPCR, RNAi, MSP-PCR, Western blot etc.",down-regulated,28057015,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MEG3,cervical cancer,"qPCR, Western blot etc.",down-regulated,23790166,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12
","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
MFI2-AS1 MELTF-AS1,cervical cancer,"qPCR, Western blot",up-regulated,31210294,Also Known As: MELTF-AS1; MFI2-AS1,1 (MELTF-AS1),NR_038285.1 (MELTF-AS1),8 (MELTF-AS1),7 (MELTF-AS1),1 (MELTF-AS1),0 (MELTF-AS1),VALIDATED (MELTF-AS1),"10 (9-C-rich, 1-3G)]","[-0.894, -0.933, -0.854,
 -0.755, -1.1, -0.935, 
-0.742, -0.857, -0.911
 (C-rich); 0.853 (3G)]","The PQS 1 (3G) of QGRS
Mapper and PQS 1 (3G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.","2 (1-C-rich, 1 -3G)","[-1.2 (C-rich), 1.478 (3G)","The PQS 1 (3G) of QGRS
Mapper and PQS 1 (3G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence."
MIAT,cervical cancer,qPCR etc.,up-regulated,32239132,Also Known As: RNCR2; GOMAFU; C22orf35; LINC00066; NCRNA00066; lncRNA-MIAT,4,"NR_003491.3, NR_033319.2, NR_033320.2, NR_033321.2","122, 118, 118, 119","94, 100, 100, 101","18, 18, 18, 18","0, 0, 0, 0",REVIEWED,"53 (29 - 2G, 17 - 3G, 6 - C-rich);
53 (29 - 2G, 17 - 3G, 6 - C-rich);
53 (29 - 2G, 17 - 3G, 6 - C-rich);
53 (29 - 2G, 17 - 3G, 6 - C-rich);
","[0.917, 0.904, 0.989, 0.766, 0.747, 0.891, 0.797, 0.894, 0.933, 0.841, 0.714, 0.926, 0.957, 0.911, 0.784, 0.882, 0.764, 0.894, 0.875, 0.92, 0.837, 0.911, 0.841, -0.933, 1.106, -0.889, 0.667, 0.816, -1.05, -0.915, 0.938, 0.933, 0.911, 0.911, 0.885, 0.73, -0.806, -0.939, 0.911, 0.872, 0.911, 1, 0.882, 0.956, 0.878, 0.911, 0.671, 0.915, 0.902, 0.896];
[0.917, 0.904, 0.989, 0.766, 0.747, 0.891, 0.797, 0.894, 0.933, 0.841, 0.714, 0.926, 0.957, 0.911, 0.784, 0.882, 0.764, 0.894, 0.875, 0.92, 0.837, 0.911, 0.841, -0.933, 1.106, -0.889, 0.667, 0.816, -1.05, -0.915, 0.938, 0.933, 0.911, 0.911, 0.885, 0.73, -0.806, -0.939, 0.911, 0.872, 0.911, 1, 0.882, 0.956, 0.878, 0.911, 0.671, 0.915, 0.902, 0.896];
[0.917, 0.904, 0.989, 0.766, 0.747, 0.891, 0.797, 0.894, 0.933, 0.841, 0.714, 0.926, 0.957, 0.911, 0.784, 0.882, 0.764, 0.894, 0.875, 0.92, 0.837, 0.911, 0.841, -0.933, 1.106, -0.889, 0.667, 0.816, -1.05, -0.915, 0.938, 0.933, 0.911, 0.911, 0.885, 0.73, -0.806, -0.939, 0.911, 0.872, 0.911, 1, 0.882, 0.956, 0.878, 0.911, 0.671, 0.915, 0.902, 0.896];
[0.917, 0.904, 0.989, 0.766, 0.747, 0.891, 0.797, 0.894, 0.933, 0.841, 0.714, 0.926, 0.957, 0.911, 0.784, 0.882, 0.764, 0.894, 0.875, 0.92, 0.837, 0.911, 0.841, -0.933, 1.106, -0.889, 0.667, 0.816, -1.05, -0.915, 0.938, 0.933, 0.911, 0.911, 0.885, 0.73, -0.806, -0.939, 0.911, 0.872, 0.911, 1, 0.882, 0.956, 0.878, 0.911, 0.671, 0.915, 0.902, 0.896];",No similarity to PQS (2G) from QGRS mapper,"6 (3G);
6 (3G);
6 (3G);
6 (3G);
6 (3G);
6 (3G);
","[1.21, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)];
[1.21, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)];
[1.21, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)];
[1.21, 1.302, 1.478, 1.422, 1.321, 1.172 (3G)]",
MIR100HG,cervical cancer,"Microarray, qPCR etc.",differential expression,27035672,Also Known As: AGD1; lncRNA-N2; linc-NeD125,23,"NR_024430.2, NR_137175.1, NR_137176.1, NR_137177.1, NR_137178.1, NR_137179.1, NR_137180.1, NR_137181.1, NR_137182.1, NR_137183.1, NR_137184.1, NR_137185.1, NR_137186.1, NR_137187.1, NR_137188.1, NR_137189.1, NR_137190.1, NR_137191.1, NR_137192.1, NR_137193.1, NR_137194.1, NR_137195.1, NR_137196.1","8, 10, 6, 6, 7, 6, 7, 8, 8, 4, 4, 4, 3, 3, 4, 7, 7, 7, 3, 5, 4, 8, 8","8, 10, 6, 6, 7, 6, 7, 8, 8, 4, 4, 4, 3, 3, 4, 7, 7, 7, 3, 5, 4, 8, 8","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"1 (2G);
3 (2G);
4 (C-rich);
4 (C-rich);
6 (1 - 2G, 5- C-rich);
6 (1 - 2G, 5- C-rich);
0;
0;
1 (2G);
1 (2G);
0;
0;
0;
0;
0;
3 (2G);
3 (2G);
3 (2G);
0;
0;
0;
5 (3-  2G, 2- C-rich);
5 (3-  2G, 2- C-rich)","[0.978 (2G)];
[0.911, 1.189, 0.943 (2G)];
[-0.564, -0.813, -1.02, -0.894 (C-rich)];
[-0.564, -0.813, -1.02, -0.894 (C-rich)];
[0.911 (2G); -0.564, -0.813, -1.02, -0.894, -0.836 (C-rich)];
[0.911 (2G); -0.564, -0.813, -1.02, -0.894, -0.836 (C-rich)];
0;
0;
[0.978 (2G)];
[0.978 (2G)];
0;
0;
0;
0;
0;
[0.911, 1.189, 0.943 (2G)];
[0.911, 1.189, 0.943 (2G)];
[0.911, 1.189, 0.943 (2G)];
0;
0;
0;
[0.896, 0.933, 1 (2G); -0.896, -1 (C-rich)];
[0.896, 0.933, 1 (2G); -0.896, -1 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
MIR205HG,cervical cancer,"qRT-PCR, RIP",up-regulated,31655037,Also known as: NPC-A-5; LINC00510,5,"NR_145437.1,NR_145433.1,NR_145434.1,NR_145435.1,NR_145436.1","5,5,6,6,4","4,4,5,5,3","1,1,1,1,1","0,0,0,0,0",VALIDATED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
MIR205HG,cervical cancer,"qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc.",up-regulated,31023531,Also known as: NPC-A-5; LINC00510,5,"NR_145437.1,NR_145433.1,NR_145434.1,NR_145435.1,NR_145436.1","5,5,6,6,4","4,4,5,5,3","1,1,1,1,1","0,0,0,0,0",VALIDATED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
MIR210HG,cervical cancer,"RT-PCR, Western blot",up-regulated,32087604,,1,NR_038262.1,29,26,3,0,VALIDATED,"12 (3-C-rich, 5-3G, 4-2G)","[1.015, 0.936, 0.9,  1.0570.891,0.936 (3G)
0.894 ,0.824, 0.911 (2G); -0.875,
-0.933, -0.7 (C-rich)]","The PQS 1 (3G) of QGRS
Mapper and PQS 1 (3G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.",1 (3G),1.354 (3G),"The PQS 1 (3G) of QGRS
Mapper and PQS 1 (3G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence."
MIR22HG,cervical cancer,qRT-PCR,down-regulated,32099468,Also Known As: C17orf91,4,"NR_028502.1, NR_028503.1, NR_028504.1, NR_028505.1","22, 16, 10, 10","20, 15, 9, 9","2, 1, 1, 1","0, 0, 0, 0",VALIDATED,"9 (2 - 2G, 7 - C-rich);
6 (1 - 2G, 5 - C-rich);
2 (C-rich);
3 (C-rich)","[0.726, 0.981 (2G); -0.765, -0.926, -1.122, -0.721,  -0.911, -0.891, -0.911 (C-rich)];
[0.981 (2G),-0.765, -0.926, -0.911, -0.891, -0.911 (C-rich)];
[-0.909, -0.911 (C-rich)];
[-0.765, -0.926,  -0.911 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"1 (C-rich);
0;
0;
0","[-1.306 (C-rich)];
0;
0;
0",No similarity to PQS (3G) from QGRS mapper
MIR503HG,cervical squamous cell carcinoma,"qPCR, Western blot etc",down-regulated,32184661,Also Known As: H19X; MIR503HG2,1,NR_024607.1,6,6,0,0,VALIDATED,2 (C-rich),"[-0.854, -0.889 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
MNX1-AS1,cervical cancer,"qPCR, Western blot, other",up-regulated,30302806,Also Known As: MAYA; CCAT5,1,NR_038835.1,12,10,2,0,VALIDATED,4 (C-rich),"[-0.963, -0.913, -0.978, -0.683 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,1 (C-rich),[-1.362 (C-rich)],No similarity to PQS (3G) from QGRS mapper
"NCK1-AS1
NCK1-DT",cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi, RIP, other",up-regulated,30221354,Also Known As: NCK1-DT; NCK1-AS1; SLC35G2-AS1,3 (NCK1-DT),"NCK1-DT (NR_110175.1, NR_110176.1, NR_110177.1)","9, 8, 7 (NCK1-DT)","9, 8, 7 (NCK1-DT)","0, 0, 0 (NCK1-DT)","0, 0, 0 (NCK1-DT)",VALIDATED (NCK1-DT),"3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G)","[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)]",,0,0,"No PQS found on 
G4 Hunter"
"NCK1-AS1
NCK1-DT",cervical cancer,"qPCR, Western blot, Luciferase reporter assay, other",up-regulated,31410182,Also Known As: NCK1-DT; NCK1-AS1; SLC35G2-AS1,3 (NCK1-DT),"NCK1-DT (NR_110175.1, NR_110176.1, NR_110177.1)","9, 8, 7 (NCK1-DT)","9, 8, 7 (NCK1-DT)","0, 0, 0 (NCK1-DT)","0, 0, 0 (NCK1-DT)",VALIDATED (NCK1-DT),"3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G)","[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)]",,0,0,"No PQS found on 
G4 Hunter"
"NCK1-AS1
NCK1-DT",cervical cancer,"Microarray, qRT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29416014,Also Known As: NCK1-DT; NCK1-AS1; SLC35G2-AS1,3 (NCK1-DT),"NCK1-DT (NR_110175.1, NR_110176.1, NR_110177.1)","9, 8, 7 (NCK1-DT)","9, 8, 7 (NCK1-DT)","0, 0, 0 (NCK1-DT)","0, 0, 0 (NCK1-DT)",VALIDATED (NCK1-DT),"3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G)","[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)]",,0,0,"No PQS found on 
G4 Hunter"
NEAT1,cervical cancer,"qRT-PCR, Western blot",up-regulated,32151082,Also Known As: VINC; TncRNA; LINC00084; NCRNA00084,2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
NEAT1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,32368085,Also Known As: VINC; TncRNA; LINC00084; NCRNA00084,2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
NEAT1,cervical cancer,"qPCR, Western blot",up-regulated,30127216,Also Known As: VINC; TncRNA; LINC00084; NCRNA00084,2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
NEAT1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,30096244,Also Known As: VINC; TncRNA; LINC00084; NCRNA00084,2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
NEAT1,cervical cancer,"qPCR, Western blot",up-regulated,30024596,Also Known As: VINC; TncRNA; LINC00084; NCRNA00084,2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
NEAT1,cervical cancer,"qPCR, Luciferase reporter assay, Western blot, RIP",up-regulated,29416780,Also Known As: VINC; TncRNA; LINC00084; NCRNA00084,2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
NEAT1,cervical cancer,"qPCR, Luciferase reporter assay, in vitro knockdown",up-regulated,29207151,Also Known As: VINC; TncRNA; LINC00084; NCRNA00084,2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS."
NKILA,cervical squamous cell carcinoma,RT-qPCR,down-regulated,31950510,,1,NR_131157.1,28,26,2,0,VALIDATED,"8 (3 - 2G, 5 - C-rich)","[0.643, 0.973, 0.911 (2G),  -0.911, -0.875, -0.8, -0.891, -0.646 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
NNT-AS1,cervical cancer,qPCR etc.,up-regulated,28628975,,1,NR_073113.1,15,15,0,0,VALIDATED,6 (C-rich),"[-1, -1.099, -0.933, -0.911, -0.851, -0.843 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter
NORAD,cervical cancer,"qPCR, RIP, Dual Luciferase Reporter Assay, Western blot",up-regulated,30119219,Also Known As: LINC00657,1,NR_027451.1,30,25,5,0,VALIDATED,"12 (7 - 2G, 5 - C-rich)","[-0.911, -0.882, -0.825, -1.118, -0.938, 0.894, 0.778, 0.681, 0.911, 0.75, 1.167, 0.824]  ",No similarity to any PQS (2G) from QGRS mapper,2 (3G),"[1.337, 1.354 (3G)]",
NR_024008.1 WWC2-AS2,cervical cancer,"Microarray, qPCR etc.",up-regulated,26054679,Also known as: C4orf38,1 (WWC2-AS2),NR_024008.1 (WWC2-AS2),28 (WWC2-AS2),27 (WWC2-AS2),1 (WWC2-AS2),0 (WWC2-AS2),VALIDATED (WWC2-AS2),"14 (5-C-rich, 2-3G, 7-2G)","[-0.652, -0.656, -0.841,
 -0.978, -0.709 (C-rich);
 0.9, 0.911, 0.759,0.898, 0.875, 
0.891, 1.021 (2G) 0.935,0.925, (3G)]","The PQS 1 (3G) of QGRS
Mapper and PQS 2 (3G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.",0,0,"No PQS found on 
G4 Hunter"
NR_034077.1 THAP9-AS1_Variant 3,cervical cancer,"Microarray, qPCR etc.",up-regulated,26054679,,"1 
(Variant 1st and 2nd are also LncRNAs)
(Total=3) (THAP9-AS1)","THAP9-AS1 (_____, _____, NR_034077.1)","_____, _____, 10 (THAP9-AS1)","_____,  _____, 10 (THAP9-AS1)","_____,  _____, 0 (THAP9-AS1)","_____,  _____, 0 (THAP9-AS1)",VALIDATED (THAP9-AS1),0,,,0,0,"No PQS found on 
G4 Hunter"
NR_037645.1 TMX2_Variant 4,cervical cancer,"Microarray, qPCR etc.",up-regulated,26054679,Also known as: PIG26; CGI-31; PDIA12; NEDMCMS; TXNDC14,"1
(Variant 4th, 12th, 13th and 14th are also lncRNAs)
(All other variants are mRNA)
(Total=14) (TMX2)","TMX2 (_____, _____, _____, NR_037645.1, _____, _____, _____, _____, _____, _____, _____, _____, _____, _____)","_____, _____, _____, 13, _____, _____, _____, _____, _____, _____, _____, _____, _____, _____,  (TMX2)","_____, _____, _____, 13, _____, _____, _____, _____, _____, _____, _____, _____, _____, _____,  (TMX2)","_____, _____, _____, 0, _____, _____, _____, _____, _____, _____, _____, _____, _____, _____,  (TMX2)","_____, _____, _____, 0, _____, _____, _____, _____, _____, _____, _____, _____, _____, _____,  (TMX2)",VALIDATED (TMX2),"7 (5-2G, 2-C-rich)","[0.911, 0.911, 0.894, 
0.88, 0.911 (2G), -0.925, -0.69 (C-rich)]
",,0,0,"No PQS found on 
G4 Hunter"
NR_037793.1 LRR1_Variant 5,cervical cancer,"Microarray, qPCR etc.",up-regulated,26054679,Also known as: LRR-1; PPIL5; 4-1BBLRR,"1
(Variant 1st and 3rd are mRNA; 4th is also lncRNA)
(Variant 2nd is not available)
(Total=5) (LRR1)","LRR1 (_____, _____, _____, _____, _____, NR_037793.1)","_____, _____, _____, _____, _____, 7 (LRR1)","_____, _____, _____, _____, _____, 7 (LRR1)","_____, _____, _____, _____, _____, 0 (LRR1)","_____, _____, _____, _____, _____, 0 (LRR1)",REVIEWED (LRR1),0,0,,0,0,"No PQS found on 
G4 Hunter"
NR_038940.1  SH3PXD2A-AS1,cervical cancer,"Microarray, qPCR etc.",up-regulated,26054679,,1 (SH3PXD2A-AS1),SH3PXD2A-AS1 (NR_038940.1),10 (SH3PXD2A-AS1),10 (SH3PXD2A-AS1),0 (SH3PXD2A-AS1),0 (SH3PXD2A-AS1),VALIDATED (SH3PXD2A-AS1),"3 (1-2G, 2-C-rich)","[-0.911, -0.903 (C-rich);
 0.933 (2G)]",,0,0,"No PQS found on 
G4 Hunter"
NR_047677.1  TARS1_Variant 5,cervical cancer,"Microarray, qPCR etc.",up-regulated,26054679,Also known as: TARS; TTD7; ThrRS; TARS1,"1
(Variant 1st , 2nd and 3rd are mRNA; 4th and 6th are also lncRNAs)
(Total=6)
(TARS1)","TARS1 (_____, _____, _____, _____, NR_047677.1, _____)","_____, _____, _____, _____, 19, _____  (TARS1)","_____, _____, _____, _____, 19, _____  (TARS1)","_____, _____, _____, _____, 0, _____ (TARS1)","_____, _____, _____, _____, 0, _____ (TARS1)",REVIEWED (TARS1),"5 (1-2G, 4-C-rich)","[0.875 (2G), -0.891, 
-0.87, -0.911, -0.933 (C-rich)]",,0,0,"No PQS found on 
G4 Hunter"
OIP5-AS1,cervical cancer,"western blot, RT-qPCR, Luciferase reporter assay, RIP",up-regulated,31939597,Also Known As: cyrano; linc-OIP5,4,"NR_026757.2, NR_152820.1, NR_152821.1, NR_152822.1","30, 26, 6, 31","30, 26, 6, 31","0,0,0,0","0,0,0,0",REVIEWED,"8 (3 - 2G, 5 - C-rich);
8 (3 - 2G, 5 - C-rich);
1 (C-rich)
8 (3 - 2G, 5 - C-rich);","[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[-0.872 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
OIP5-AS1,cervical cancer,"qPCR, Luciferase reporter assay, Western blot, RIP",up-regulated,30188591,Also Known As: cyrano; linc-OIP5,4,"NR_026757.2, NR_152820.1, NR_152821.1, NR_152822.1","30, 26, 6, 31","30, 26, 6, 31","0,0,0,0","0,0,0,0",REVIEWED,"8 (3 - 2G, 5 - C-rich);
8 (3 - 2G, 5 - C-rich);
1 (C-rich)
8 (3 - 2G, 5 - C-rich);","[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[-0.872 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
OIP5-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi, other",up-regulated,30341904,Also Known As: cyrano; linc-OIP5,4,"NR_026757.2, NR_152820.1, NR_152821.1, NR_152822.1","30, 26, 6, 31","30, 26, 6, 31","0,0,0,0","0,0,0,0",REVIEWED,"8 (3 - 2G, 5 - C-rich);
8 (3 - 2G, 5 - C-rich);
1 (C-rich)
8 (3 - 2G, 5 - C-rich);","[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[-0.872 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
OIP5-AS1,cervical cancer,"qPCR, RIP etc.",differential expression,26819413,Also Known As: cyrano; linc-OIP5,4,"NR_026757.2, NR_152820.1, NR_152821.1, NR_152822.1","30, 26, 6, 31","30, 26, 6, 31","0,0,0,0","0,0,0,0",REVIEWED,"8 (3 - 2G, 5 - C-rich);
8 (3 - 2G, 5 - C-rich);
1 (C-rich)
8 (3 - 2G, 5 - C-rich);","[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];
[-0.872 (C-rich)];
[0.649, 0.656, 0.915 (2G); -0.911, -0.911, -0.851, -0.84, -0.911 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PANDAR,cervical cancer,qPCR etc.,up-regulated,29131264,Also Known As: PANDA,1,NR_109836.1,6,6,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
PCAT1,cervical cancer,"qPCR, in vitro knockdown etc.",down-regulated,29687842,"Also Known As: PCA1; PiHL; PCAT-1.Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
PCAT6,cervical cancer,"qRT-PCR, Western blot, RIP",up-regulated,32103984,Also Known As: PCAN-R1; KDM5BAS1; ncRNA-a2; KDM5B-AS1; onco-lncRNA-96,2,"NR_046325.1, NR_046326.1","4,3","3,2","1,1","0,0",VALIDATED,"12 (2 - 2G; 10 - C-rich);
10( 2 - 2G; 8 - C-rich)","[0.935, 0.804 (2G); -0.862, -0.957, -0.915, -0.918, -0.865, -0.911, -0.896, -0.914, -0.945, -0.915 (C-rich)];
[0.935, 0.804 (2G); -0.862, -0.957, -0.915, -0.918, -0.865, -0.911, -0.896, -0.914 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"2 (C-rich);
1 (C-rich)","[ 1.417 (3G); -1.3 (C-rich)];
[-1.3 (C-rich)]",No similarity to PQS from QGRS Mapper
PCAT6,cervical cancer,qPCR,up-regulated,30915737,Also Known As: PCAN-R1; KDM5BAS1; ncRNA-a2; KDM5B-AS1; onco-lncRNA-96,2,"NR_046325.1, NR_046326.1","4,3","3,2","1,1","0,0",VALIDATED,"12 (2 - 2G; 10 - C-rich);
10( 2 - 2G; 8 - C-rich)","[0.935, 0.804 (2G); -0.862, -0.957, -0.915, -0.918, -0.865, -0.911, -0.896, -0.914, -0.945, -0.915 (C-rich)];
[0.935, 0.804 (2G); -0.862, -0.957, -0.915, -0.918, -0.865, -0.911, -0.896, -0.914 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"2 (C-rich);
1 (C-rich)","[ 1.417 (3G); -1.3 (C-rich)];
[-1.3 (C-rich)]",No similarity to PQS from QGRS Mapper
PCGEM1,cervical cancer,"Western blot analysis, qRT-PCR, RIP, Luciferase reporter assays",up-regulated,31832017,Also Known As: PCGEM1 ; LINC00071; NCRNA00071,2,"NR_002769.1, NR_152587.1","7,8","7,8","0,0","0,0",REVIEWED,0,0,,,,
PTCSC3,cervical cancer,qRT-PCR,down-regulated,31814920,,1,NR_049735.2,8,8,0,,VALIDATED,1 (2G),0.709 (2G),,0,0,No PQS found in G4 Hunter
PTCSC3,cervical cancer,"qRT-PCR , Luciferase reporter assay , Western blot etc.",down-regulated,31587336,,1,NR_049735.2,8,8,0,,VALIDATED,1 (2G),0.709 (2G),,0,0,No PQS found in G4 Hunter
PVT1,cervical cancer,"qRT-PCR, Western-blot assays",up-regulated,31943014,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical cancer,qPCR,up-regulated,30134241,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay",up-regulated,31322217,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical squamous cell carcinoma,"qPCR, Western blot etc.",up-regulated,29760583,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical cancer,"qPCR, RNAi, Western blot, RIP, ChIP, Dual luciferase reporter assay, RNA pull-down assay, Cell proliferation assay etc.",up-regulated,28296507,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical cancer,qPCR etc.,up-regulated,27775803,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical cancer,"qPCR, RNAi, Western blot, Cell proliferation assay etc.",up-regulated,27232880,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical cancer,"qPCR, RNAi, Luciferase reporter assay, Cell proliferation assay etc.",up-regulated,28276314,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
PVT1,cervical cancer,"qPCR, RNAi, Western blot, RIP, ChIP, RNA pull-down assay etc.",up-regulated,27272214,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100.Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.",1,NR_003367.3,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
RHPN1-AS1,cervical cancer,"qPCR, western blot",up-regulated,31525429,Also known as: C8orf51,1,NR_026785.1,16,16,0,0,VALIDATED,6 (C-rich),"[-0.911, -0.978, -0.918, -0.933, -0.818 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
ROR1-AS1,cervical cancer,"qPCR, Western blot etc",up-regulated,32271410,,2,"NR_110665.1, NR_110666.1","7,11","7,11","0,0","0,0",VALIDATED,0,0,,,,
SBF2-AS1,cervical cancer,qPCR,up-regulated,30856345,,1,NR_036485.1,13,11,2,0,VALIDATED,3 (2G),"[0.956, 0.84, 0.85 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SNHG1,cervical cancer,"Microarray, qRT-PCR",up-regulated,28930646,Also Known As: UHG; U22HG; lncRNA16; LINC00057; NCRNA00057,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1, NR_152582.1, NR_152583.1, NR_152584.1, NR_152585.1","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter
SNHG12,cervical squamous cell carcinoma,"qRT-PCR, Western blot analysis",up-regulated,31943193,Also Known As: C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100,8,"NR_024127.2, NR_146381.1, NR_146382.1, NR_146383.1, NR_146384.1, NR_146385.1, NR_146386.1, NR_146387.1","8, 13, 9, 8, 13, 8, 8, 11","8, 13, 9, 8, 13, 8, 8, 11","0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
1 (C-rich);
0;
0;
1 (2G);
0;
0
","
0;
0;
[-0.945 (C-rich)];
0;
0;
[0.875 (2G)];
0;
0",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter
SNHG12,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP, RNAi, other",up-regulated,30246459,Also Known As: C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100,8,"NR_024127.2, NR_146381.1, NR_146382.1, NR_146383.1, NR_146384.1, NR_146385.1, NR_146386.1, NR_146387.1","8, 13, 9, 8, 13, 8, 8, 11","8, 13, 9, 8, 13, 8, 8, 11","0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
1 (C-rich);
0;
0;
1 (2G);
0;
0
","
0;
0;
[-0.945 (C-rich)];
0;
0;
[0.875 (2G)];
0;
0",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter
SNHG12,cervical cancer,"qPCR, Luciferase reporter assay",up-regulated,29533945,Also Known As: C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100,8,"NR_024127.2, NR_146381.1, NR_146382.1, NR_146383.1, NR_146384.1, NR_146385.1, NR_146386.1, NR_146387.1","8, 13, 9, 8, 13, 8, 8, 11","8, 13, 9, 8, 13, 8, 8, 11","0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
1 (C-rich);
0;
0;
1 (2G);
0;
0
","
0;
0;
[-0.945 (C-rich)];
0;
0;
[0.875 (2G)];
0;
0",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter
SNHG14,cervical cancer,"qRT-PCR , Western blot , in vitro knockdown etc.",up-regulated,31114991,Also Known As: 115HG; LNCAT; UBE3A-AS; UBE3AATS; UBE3A-AS1; UBE3A-ATS; NCRNA00214; U-UBE3A-ATS; IC-SNURF-SNRPN,1,NR_146177.1,176,175,1,0,REVIEWED,"20 (4 - 2G, 16 - C-rich)","[0.84, 0.84, 0.911, -0.915, -0.764, -0.741, 0.911, -0.852, -0.979, -0.894, -0.882, -0.978, -0.912, -0.911, -0.891, -0.911, -1.146, -0.872, -0.911, -1.146] ",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SNHG14,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP, etc.",up-regulated,30611620,Also Known As: 115HG; LNCAT; UBE3A-AS; UBE3AATS; UBE3A-AS1; UBE3A-ATS; NCRNA00214; U-UBE3A-ATS; IC-SNURF-SNRPN,1,NR_146177.1,176,175,1,0,REVIEWED,"20 (4 - 2G, 16 - C-rich)","[0.84, 0.84, 0.911, -0.915, -0.764, -0.741, 0.911, -0.852, -0.979, -0.894, -0.882, -0.978, -0.912, -0.911, -0.891, -0.911, -1.146, -0.872, -0.911, -1.146] ",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SNHG16,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc",up-regulated,31774223,Also Known As: SNHG16; ncRAN; Nbla10727; Nbla12061,4,"NR_038108.1, NR_038109.1, NR_038110.1, NR_038111.1","9,9,8,8","9,9,8,8","0,0,0,0","0,0,0,0",VALIDATED,"1  (C-rich);
1  (C-rich);
1  (C-rich);
1  (C-rich)","[-0.819 (C-rich)];
[-0.819 (C-rich)];
[-0.819 (C-rich)];
[-0.819 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SNHG16,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,29126969,Also Known As: SNHG16; ncRAN; Nbla10727; Nbla12061,4,"NR_038108.1, NR_038109.1, NR_038110.1, NR_038111.1","9,9,8,8","9,9,8,8","0,0,0,0","0,0,0,0",VALIDATED,"1  (C-rich);
1  (C-rich);
1  (C-rich);
1  (C-rich)","[-0.819 (C-rich)];
[-0.819 (C-rich)];
[-0.819 (C-rich)];
[-0.819 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SNHG20,cervical cancer,qPCR etc.,up-regulated,29604594,Also Known As: C17orf86; LINC00338; NCRNA00338; SCARNA16HG,1,NR_027058.1,18,17,1,0,VALIDATED,3 (2G),"[1.104, 0.753, 0.774]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SNHG4,cervical cancer,"qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc.",up-regulated,31590627,"Also Known As: NCRNA00059, U19H",2,"NR_003141.3, NR_036536.1","10,8","10,8","0,0","0,0",VALIDATED,"4 (2 - 2G, 2 - C-rich);
2 (C-rich)","[0.911 ,  0.891 (2G), -0.754, -0.8 (C-rich)];
[-0.754, -0.8 (C-rich)]
",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SNHG7,cervical cancer,"RT-qPCR, Western blot",up-regulated,32161467,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28,13,12","23,10,9","5,3,3","0,0,0",VALIDATED,"8 (2G)
3 (1 - 2G, 2 - C-rich)
2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];
[0.826 (2G); -0.957,  -0.911 (C-rich)] ;
[0.826, 0.8 (2G)] 
",No similarity to PQS (2G) from QGRS mapper,"3 (3G);
2 (3G);
2 (3G)","[1.348, 1.292, 1.444 (3G)];
[1.348, 1.292 (3G)];
[1.348, 1.292 (3G)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter
SNHG7,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc",up-regulated,32275170,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28,13,12","23,10,9","5,3,3","0,0,0",VALIDATED,"8 (2G)
3 (1 - 2G, 2 - C-rich)
2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];
[0.826 (2G); -0.957,  -0.911 (C-rich)] ;
[0.826, 0.8 (2G)] 
",No similarity to PQS (2G) from QGRS mapper,"3 (3G);
2 (3G);
2 (3G)","[1.348, 1.292, 1.444 (3G)];
[1.348, 1.292 (3G)];
[1.348, 1.292 (3G)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter
SNHG7,cervical cancer,"qPCR, Western blot etc",up-regulated,31773679,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28,13,12","23,10,9","5,3,3","0,0,0",VALIDATED,"8 (2G)
3 (1 - 2G, 2 - C-rich)
2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];
[0.826 (2G); -0.957,  -0.911 (C-rich)] ;
[0.826, 0.8 (2G)] 
",No similarity to PQS (2G) from QGRS mapper,"3 (3G);
2 (3G);
2 (3G)","[1.348, 1.292, 1.444 (3G)];
[1.348, 1.292 (3G)];
[1.348, 1.292 (3G)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter
SNHG8,cervical cancer,"qRT-PCR, Western blot assay, RIP",up-regulated,31961005,Also known as: LINC00060; NCRNA00060,3,"NR_003584.3,NR_034010.1,NR_034011.1","5,4,2","5,3,2","0,1,0","0,0,0",VALIDATED,0,0,,,,
SOX21-AS1,cervical cancer,qPCR,up-regulated,30912129,,1,NR_046514.1,21,20,1,0,VALIDATED,"5 (1 - 2G, 4 - C-rich)","[-0.911, -.0913, 0.746, -1, -0.911 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SOX2OT,cervical cancer,"qPCR, Western blot etc.",differential expressed,32286144,"Some (older) SOX2OT transcript variant 7 lncRNA ""lncRNA"" ncRNA (complete sequence-KF981435.1) was also there in result.
","6 (SOX2-OT_Variant 1-6)
+
1 [SOX2-OT_Variant 7 (older)]
=7","SOX2-OT_Variant 1-6 (NR_075091.1, NR_075092.1, NR_075093.1, NR_004053.3, NR_075089.1, NR_075090.1)
+
SOX2OT_Variant 7 (older) (KF981435.1)","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","0, 0, 0, 0, 0, 0 (SOX2-OT_Variant 1-6)
+
0 [SOX2OT_Variant 7 (older)]","0, 0, 0, 0, 0, 0 (SOX2-OT_Variant 1-6)
+
0 [SOX2OT_Variant 7 (older)]",REVIEWED,"5 (3 - 2G, 3 - C-rich);
5 (3 - 2G, 3 - C-rich);
3 (1 - 2G, 2 - C-rich);
5 (3 - 2G, 3 - C-rich);
5 (3 - 2G, 3 - C-rich);
2 (C-rich)","[0.911, 0.933,  0.915, -0.811,  -0.6];
[0.911, 0.933,  0.915, -0.811,  -0.6];
[0.764, -0.811, -0.6];
[0.911, 0.933,  0.915, -0.811,  -0.6];
[0.911, 0.933,  0.915, -0.811,  -0.6];
[-0.811, -0.6]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SOX2OT,cervical cancer,qPCR etc.,up-regulated,26703382,"Some (older) SOX2OT transcript variant 7 lncRNA ""lncRNA"" ncRNA (complete sequence-KF981435.1) was also there in result.
","6 (SOX2-OT_Variant 1-6)
+
1 [SOX2-OT_Variant 7 (older)]
=7","SOX2-OT_Variant 1-6 (NR_075091.1, NR_075092.1, NR_075093.1, NR_004053.3, NR_075089.1, NR_075090.1)
+
SOX2OT_Variant 7 (older) (KF981435.1)","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","18, 16, 13, 16, 15, 11 (SOX2-OT_Variant 1-6)
+
11 [SOX2OT_Variant 7 (older)]","0, 0, 0, 0, 0, 0 (SOX2-OT_Variant 1-6)
+
0 [SOX2OT_Variant 7 (older)]","0, 0, 0, 0, 0, 0 (SOX2-OT_Variant 1-6)
+
0 [SOX2OT_Variant 7 (older)]",REVIEWED,"5 (3 - 2G, 3 - C-rich);
5 (3 - 2G, 3 - C-rich);
3 (1 - 2G, 2 - C-rich);
5 (3 - 2G, 3 - C-rich);
5 (3 - 2G, 3 - C-rich);
2 (C-rich)","[0.911, 0.933,  0.915, -0.811,  -0.6];
[0.911, 0.933,  0.915, -0.811,  -0.6];
[0.764, -0.811, -0.6];
[0.911, 0.933,  0.915, -0.811,  -0.6];
[0.911, 0.933,  0.915, -0.811,  -0.6];
[-0.811, -0.6]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
SPRY4-IT1,cervical cancer,"qRT-PCR, Western blotting, in vitro knockdown etc.",up-regulated,31092700,Also Known As: SPRIGHTLY,1,NR_131221.1,5,5,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
SPRY4-IT1,cervical cancer,qPCR etc.,up-regulated,27642559,Also Known As: SPRIGHTLY,1,NR_131221.1,5,5,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter
STXBP5-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP",down-regulated,31212131,,1,NR_034115.1,14,13,0,1,VALIDATED,"6 (1-4G, 5-C-rich)","[0.733 (4G); -0.854, 
-0.957, -0.732, -0.911, -0.918 (C-rich)]","The PQS 1 (3G) of QGRS
Mapper and PQS 1 (4G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.",0,0,No PQS found on G4 Hunter
TDRG1,cervical cancer,"qRT-PCR, Western blot",up-regulated,32106739,Also known as: LINC00532; lincRNA-NR_024015,3,"NR_160958.1,NR_160959.1,NR_160960.1","8,6,6","8,6,6","0,0,0","0,0,0",VALIDATED,"5 (C-rich);
5 (C-rich);
5 (C-rich);","[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);

[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);

[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);",,0,0,No PQS found on G4 Hunter
TDRG1,cervical cancer,"qPCR, Luciferase reporter assay, Western blot, RIP",up-regulated,31539116,Also known as: LINC00532; lincRNA-NR_024015,3,"NR_160958.1,NR_160959.1,NR_160960.1","8,6,6","8,6,6","0,0,0","0,0,0",VALIDATED,"5 (C-rich);
5 (C-rich);
5 (C-rich);","[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);

[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);

[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);",,0,0,No PQS found on G4 Hunter
TDRG1,cervical cancer,"qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc.",up-regulated,31164797,Also known as: LINC00532; lincRNA-NR_024015,3,"NR_160958.1,NR_160959.1,NR_160960.1","8,6,6","8,6,6","0,0,0","0,0,0",VALIDATED,"5 (C-rich);
5 (C-rich);
5 (C-rich);","[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);

[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);

[-1, -0.83, -0.836, -0.878, -0.8 (C-rich);",,0,0,No PQS found on G4 Hunter
TINCR,cervical squamous cell carcinoma,"qRT-PCR, Western blotting etc.",up-regulated,30993776,Also Known As: PLAC2; LINC00036; NCRNA00036; onco-lncRNA-16,1,NR_027064.3,40,30,10,0,REVIEWED,"24 ( 15- 2G, 9 - C-rich)","[1.184, 1.04, 0.936, 0.884, 0.877, 0.87, -0.836, -0.978, -1, 0.766, 1.136, 0.885, 0.865, 0.655, 0.542, -0.847, -0.833, -0.774, -0.956, 1, 0.911, 0.745, -1.075, -0.891]",No similarity to PQS (2G) from QGRS mapper,"10 (2 - 3G, 8 - C-rich)","[1.373, 1.604 (3G); -1.391, -1.422, -1.354, 1.347, -1.4, -1.5, -1.489, -1.375 (C-rich)]",No similarity to PQS from QGRS Mapper
TINCR,cervical squamous cell carcinoma,"qPCR, Western blot, Luciferase reporter assay",up-regulated,31388923,Also Known As: PLAC2; LINC00036; NCRNA00036; onco-lncRNA-16,1,NR_027064.3,40,30,10,0,REVIEWED,"24 ( 15- 2G, 9 - C-rich)","[1.184, 1.04, 0.936, 0.884, 0.877, 0.87, -0.836, -0.978, -1, 0.766, 1.136, 0.885, 0.865, 0.655, 0.542, -0.847, -0.833, -0.774, -0.956, 1, 0.911, 0.745, -1.075, -0.891]",No similarity to PQS (2G) from QGRS mapper,"10 (2 - 3G, 8 - C-rich)","[1.373, 1.604 (3G); -1.391, -1.422, -1.354, 1.347, -1.4, -1.5, -1.489, -1.375 (C-rich)]",No similarity to PQS from QGRS Mapper
TMPO-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay etc",up-regulated,32184662,,1,NR_027157.1,18,17,1,0,VALIDATED,"6 (5-C-rich, 1-3G)","[-0.778, -0.911, -0.695, -0.82, -0.911 (C-rich);
0.774 (3G)]","The PQS 1 (3G) of QGRS
Mapper and PQS 1 (4G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.",0,0,No PQS found on G4 Hunter
TMPO-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.",up-regulated,31483914,,1,NR_027157.1,18,17,1,0,VALIDATED,"6 (5-C-rich, 1-3G)","[-0.778, -0.911, -0.695, -0.82, -0.911 (C-rich);
0.774 (3G)]","The PQS 1 (3G) of QGRS
Mapper and PQS 1 (4G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.",0,0,No PQS found on G4 Hunter
TOB1-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, other",down-regulated,30210918,,1,NR_038458.1,14,9,4,1,VALIDATED,"9 (2-C-rich, 5-3G, 1-2G, 1-4G)","[1.167, 0.887, 0.922, 
0.851,0.538 (3G)
0.956 (4G) 0.911 (2G)  -0.805,-0.936]","The PQS 1 (3G) of QGRS
Mapper and PQS 5 (3G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.
The PQS 2 (3G) of QGRS
Mapper and PQS 6 (4G)
of G4 hunter are similar
with the same G tracts 
with additional nucleotides
surrounding the G4 
sequence.",8,"[1.435, 1.4, 1.354, 1.34,
1.34, -1.246, 1.474, 
1.435]",
TP73-AS1,cervical cancer,"qRT-PCR, RIP, Dual luciferase reporter assay, Western blot",up-regulated,31663517,Also Known As: PDAM; KIAA0495,5,"NR_033711.1, NR_033710.1, NR_033709.1, NR_033708.1, NR_033712.1","67, 58, 46, 38, 30","61, 52, 41, 33, 26","6, 6, 5, 5, 4","0, 0, 0, 0, 0",VALIDATED,"21 (9 - 2G, 12 - C-rich), 
21 (9 - 2G, 12 - C-rich), 
19 (8 - 2G, 11 - C-rich), 
18 (7 - 2G, 11 - C-rich),
6 (2G)","[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.726, -0.704, 0.913, 0.896, 0.793, 0.894, 0.915]; 
[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.726, -0.704, 0.913, 0.896, 0.793, 0.894, 0.915];
[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.913, 0.896, 0.793, 0.894, 0.915]; 
[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.896, 0.793, 0.894, 0.915]; 
[0.827, 1.019, 0.896, 0.793, 0.894, 0.915]
",No similarity to PQS (2G) from QGRS mapper,"7 (3 - 3G, 4 - C-rich), 
7 (3 - 3G, 4 - C-rich), 
7 (3 - 3G, 4 - C-rich), 
7 (3 - 3G, 4 - C-rich), 
2 (3G)","[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404 (3G)] ",Some PQS from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter
TP73-AS1,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, RIP",up-regulated,31232491,Also Known As: PDAM; KIAA0495,5,"NR_033711.1, NR_033710.1, NR_033709.1, NR_033708.1, NR_033712.1","67, 58, 46, 38, 30","61, 52, 41, 33, 26","6, 6, 5, 5, 4","0, 0, 0, 0, 0",VALIDATED,"21 (9 - 2G, 12 - C-rich), 
21 (9 - 2G, 12 - C-rich), 
19 (8 - 2G, 11 - C-rich), 
18 (7 - 2G, 11 - C-rich),
6 (2G)","[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.726, -0.704, 0.913, 0.896, 0.793, 0.894, 0.915]; 
[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.726, -0.704, 0.913, 0.896, 0.793, 0.894, 0.915];
[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.913, 0.896, 0.793, 0.894, 0.915]; 
[0.911, 0.896, -0.986, -0.911, -0.92, -0.933, -1.022, -0.085, -0.0759, -1, -0.933, -0.933, -0.827, 1.019, 0.896, 0.793, 0.894, 0.915]; 
[0.827, 1.019, 0.896, 0.793, 0.894, 0.915]
",No similarity to PQS (2G) from QGRS mapper,"7 (3 - 3G, 4 - C-rich), 
7 (3 - 3G, 4 - C-rich), 
7 (3 - 3G, 4 - C-rich), 
7 (3 - 3G, 4 - C-rich), 
2 (3G)","[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404, 1.391 [3G]
-1.053, -1.4, -1.435, -1.457 (C-rich)];
[1.408, 1.404 (3G)] ",Some PQS from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter
TPT1-AS1,cervical cancer,"qPCR, Western blot",up-regulated,30045766,,1,NR_024458.1,12,12,0,0,VALIDATED,0,0,,,,
TTN-AS1,cervical cancer,"qPCR, Western blot, Luciferase assay, RIP",up-regulated,30135013,,2,"NR_038272.1, NR_038271.1","32,13","32,13","0,0","0,0",VALIDATED,"5 (2G)
3 (2-2G, 1-C-rich)","[0.911, 0.8, 0.658, 
0.958, 0.911 (2G)];

[0.922, 0.894 (2G); 
-0.915 (C-rich)]",,0,0,No PQS found on G4 Hunter
TUG1,cervical cancer,"qPCR, Western blot, RIP",up-regulated,31646551,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

The PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2,3 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

It appears that at a time only one G tract can be formed from PQS 2, 3 of G4 Hunter due to overlapping sequences.

The PQS 3 (3G) from QGRS mapper is similar to / a part of PQS 4 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

The PQS 4(3G) from QGRS mapper is similar to / a part of PQS 5 (3G) from G4 hunter, with a left frame-shift in G4 Hunter"
TUG1,cervical cancer,"qPCR, Western blot etc.",up-regulated,29029428,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

The PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2,3 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

It appears that at a time only one G tract can be formed from PQS 2, 3 of G4 Hunter due to overlapping sequences.

The PQS 3 (3G) from QGRS mapper is similar to / a part of PQS 4 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

The PQS 4(3G) from QGRS mapper is similar to / a part of PQS 5 (3G) from G4 hunter, with a left frame-shift in G4 Hunter"
TUG1,cervical cancer,"qPCR, RNAi, Western blot, Flow cytometry assay, Cell migration and invasion assay etc.",up-regulated,28088836,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

The PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2,3 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

It appears that at a time only one G tract can be formed from PQS 2, 3 of G4 Hunter due to overlapping sequences.

The PQS 3 (3G) from QGRS mapper is similar to / a part of PQS 4 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

The PQS 4(3G) from QGRS mapper is similar to / a part of PQS 5 (3G) from G4 hunter, with a left frame-shift in G4 Hunter"
TUSC8,cervical cancer,"qRT-PCR, Western blotting, RIP etc.",down-regulated,31033083,Also Known As: TUSC8; LINC01071; XLOC_010588,1,NR_104174.1,9,9,0,0,VALIDATED,1 (C-rich),[-0.894 (C-rich)],,0,0,No PQS found on G4 Hunter
UCA1,cervical cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,30015920,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
UCA1,cervical cancer,"qPCR, Luciferase Reporter Assay etc",up-regulated,32329829,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
UCA1,cervical cancer,"Microarray, qPCR, Western blot",up-regulated,31949782,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
UCA1,papillomavirus-mediated cervical cancer,RNA-seq etc.,up-regulated,28970820,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
UCA1,cervical cancer,qPCR etc.,up-regulated,29620291,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
UCA1,cervical cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,28414550,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
UCA1,cervical cancer,"qPCR, Western blot, Northern blot, Flow cytometry assay etc.",up-regulated,17416635,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
UCA1,cervical cancer,"qPCR, Luciferase reporter assay, in vitro knockdown etc.",up-regulated,29523226,Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36,1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter
WT1-AS,cervical cancer,"qPCR, Western blot, RIP, luciferase reporter assay etc.",down-regulated,32319820,Also Known As: WT1-AS; WIT1; WIT-1; WT1AS; WT1-AS1,5,"WT1-AS (NR_120546.1, NR_120547.1, NR_023920.2, NR_120548.1, NR_120549.1)","32, 24, 13, 13, 10","29, 22, 11, 12, 9","2, 1, 1, 1, 1 (WT1-AS)

PQS 1 and 2 of 1st variant is diferent from other variants.
PQS of 2nd, 3rd, 4th and 5th variants are same","1, 1, 1, 0, 0 (WT1-AS)",VALIDATED,"12 ( 3 - 2G, 2 - 3G, 2 - 4G, 5 - C-rich);
9  (3 - 2G, 1 - 3G, 1 - 4G, 4 - C-rich);
7 (3 - 2G, 1 - 3G, 1 - 4G, 2 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich)","[0.891, 0.891, 0.725, (2G);  0.887, 0.881 (3G); 0.931, 0.75 (4G);  -0.913, -0.911, -0.717, -0.788, -0.978 (C-rich)]; 
[0.848, 0.793, 0.667 (2G);  0.827 (3G); 0.75 (4G); -0.59,  -0.717, -0.788, -0.678 (C-rich)];
[0.848, 0.793, 0.652 (2G); 0.827 (3G); 0.75 (4G); -0.59, -0.717 (C-rich)]; 
[0.848, 0.793 (2G);  0.827 (3G); -0.59 (C-rich)]; 
[0.848, 0.793 (2G); , 0.827 (3G); -0.59 (C-rich)] 
","For Variants 1, 2, 3,
The PQS 1 (4G) from QGRS mapper is similar to / a part of PQS 1 (4G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, It appears that at a time only one G tract can be formed from PQS 1, 2 (4G) of G4 Hunter due to overlapping sequences.

For Variants 1, 2, 3, 4, 5,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter, with a left frame-shift in G4 Hunter","2 (1 - 3G, 1 - C-rich);
1 (C -rich);
 0;
 0;
 0","[1.457 (3G); -1.422 (C-rich)]; 
[-1.422 (C-rich)]","For Variant 1,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter"
WT1-AS,cervical cancer,"qPCR, Luciferase reporter assay",down-regulated,30720155,Also Known As: WT1-AS; WIT1; WIT-1; WT1AS; WT1-AS1,5,"WT1-AS (NR_120546.1, NR_120547.1, NR_023920.2, NR_120548.1, NR_120549.1)","32, 24, 13, 13, 10","29, 22, 11, 12, 9","2, 1, 1, 1, 1 (WT1-AS)

PQS 1 and 2 of 1st variant is diferent from other variants.
PQS of 2nd, 3rd, 4th and 5th variants are same","1, 1, 1, 0, 0 (WT1-AS)",VALIDATED,"12 ( 3 - 2G, 2 - 3G, 2 - 4G, 5 - C-rich);
9  (3 - 2G, 1 - 3G, 1 - 4G, 4 - C-rich);
7 (3 - 2G, 1 - 3G, 1 - 4G, 2 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich)","[0.891, 0.891, 0.725, (2G);  0.887, 0.881 (3G); 0.931, 0.75 (4G);  -0.913, -0.911, -0.717, -0.788, -0.978 (C-rich)]; 
[0.848, 0.793, 0.667 (2G);  0.827 (3G); 0.75 (4G); -0.59,  -0.717, -0.788, -0.678 (C-rich)];
[0.848, 0.793, 0.652 (2G); 0.827 (3G); 0.75 (4G); -0.59, -0.717 (C-rich)]; 
[0.848, 0.793 (2G);  0.827 (3G); -0.59 (C-rich)]; 
[0.848, 0.793 (2G); , 0.827 (3G); -0.59 (C-rich)] 
","For Variants 1, 2, 3,
The PQS 1 (4G) from QGRS mapper is similar to / a part of PQS 1 (4G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, It appears that at a time only one G tract can be formed from PQS 1, 2 (4G) of G4 Hunter due to overlapping sequences.

For Variants 1, 2, 3, 4, 5,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter, with a left frame-shift in G4 Hunter","2 (1 - 3G, 1 - C-rich);
1 (C -rich);
 0;
 0;
 0","[1.457 (3G); -1.422 (C-rich)]; 
[-1.422 (C-rich)]","For Variant 1,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter"
WT1-AS,cervical squamous cell carcinoma,"RT-qPCR, Western-blot",down-regulated,31694597,Also Known As: WT1-AS; WIT1; WIT-1; WT1AS; WT1-AS1,5,"WT1-AS (NR_120546.1, NR_120547.1, NR_023920.2, NR_120548.1, NR_120549.1)","32, 24, 13, 13, 10","29, 22, 11, 12, 9","2, 1, 1, 1, 1 (WT1-AS)

PQS 1 and 2 of 1st variant is diferent from other variants.
PQS of 2nd, 3rd, 4th and 5th variants are same","1, 1, 1, 0, 0 (WT1-AS)",VALIDATED,"12 ( 3 - 2G, 2 - 3G, 2 - 4G, 5 - C-rich);
9  (3 - 2G, 1 - 3G, 1 - 4G, 4 - C-rich);
7 (3 - 2G, 1 - 3G, 1 - 4G, 2 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich)","[0.891, 0.891, 0.725, (2G);  0.887, 0.881 (3G); 0.931, 0.75 (4G);  -0.913, -0.911, -0.717, -0.788, -0.978 (C-rich)]; 
[0.848, 0.793, 0.667 (2G);  0.827 (3G); 0.75 (4G); -0.59,  -0.717, -0.788, -0.678 (C-rich)];
[0.848, 0.793, 0.652 (2G); 0.827 (3G); 0.75 (4G); -0.59, -0.717 (C-rich)]; 
[0.848, 0.793 (2G);  0.827 (3G); -0.59 (C-rich)]; 
[0.848, 0.793 (2G); , 0.827 (3G); -0.59 (C-rich)] 
","For Variants 1, 2, 3,
The PQS 1 (4G) from QGRS mapper is similar to / a part of PQS 1 (4G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, It appears that at a time only one G tract can be formed from PQS 1, 2 (4G) of G4 Hunter due to overlapping sequences.

For Variants 1, 2, 3, 4, 5,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter, with a left frame-shift in G4 Hunter","2 (1 - 3G, 1 - C-rich);
1 (C -rich);
 0;
 0;
 0","[1.457 (3G); -1.422 (C-rich)]; 
[-1.422 (C-rich)]","For Variant 1,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter"
WT1-AS,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.",down-regulated,30666161,Also Known As: WT1-AS; WIT1; WIT-1; WT1AS; WT1-AS1,5,"WT1-AS (NR_120546.1, NR_120547.1, NR_023920.2, NR_120548.1, NR_120549.1)","32, 24, 13, 13, 10","29, 22, 11, 12, 9","2, 1, 1, 1, 1 (WT1-AS)

PQS 1 and 2 of 1st variant is diferent from other variants.
PQS of 2nd, 3rd, 4th and 5th variants are same","1, 1, 1, 0, 0 (WT1-AS)",VALIDATED,"12 ( 3 - 2G, 2 - 3G, 2 - 4G, 5 - C-rich);
9  (3 - 2G, 1 - 3G, 1 - 4G, 4 - C-rich);
7 (3 - 2G, 1 - 3G, 1 - 4G, 2 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich);
4 (2 - 2G, 1 - 3G, 1 - C-rich)","[0.891, 0.891, 0.725, (2G);  0.887, 0.881 (3G); 0.931, 0.75 (4G);  -0.913, -0.911, -0.717, -0.788, -0.978 (C-rich)]; 
[0.848, 0.793, 0.667 (2G);  0.827 (3G); 0.75 (4G); -0.59,  -0.717, -0.788, -0.678 (C-rich)];
[0.848, 0.793, 0.652 (2G); 0.827 (3G); 0.75 (4G); -0.59, -0.717 (C-rich)]; 
[0.848, 0.793 (2G);  0.827 (3G); -0.59 (C-rich)]; 
[0.848, 0.793 (2G); , 0.827 (3G); -0.59 (C-rich)] 
","For Variants 1, 2, 3,
The PQS 1 (4G) from QGRS mapper is similar to / a part of PQS 1 (4G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, It appears that at a time only one G tract can be formed from PQS 1, 2 (4G) of G4 Hunter due to overlapping sequences.

For Variants 1, 2, 3, 4, 5,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter, with a left frame-shift in G4 Hunter

For Variant 1, PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter, with a left frame-shift in G4 Hunter","2 (1 - 3G, 1 - C-rich);
1 (C -rich);
 0;
 0;
 0","[1.457 (3G); -1.422 (C-rich)]; 
[-1.422 (C-rich)]","For Variant 1,
The PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter"
XIST,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29909347,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891, 0.933, 0.836, 0.891, 0.772]",No similarity to any PQS (2G) from QGRS mapper,"9 (1 - 3G, 8 - C-rich)","[2.069 (3G); -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS from QGRS mapper
XIST,cervical cancer,"qPCR, Luciferase reporter assay, Western blot",up-regulated,30858762,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891, 0.933, 0.836, 0.891, 0.772]",No similarity to any PQS (2G) from QGRS mapper,"9 (1 - 3G, 8 - C-rich)","[2.069 (3G); -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS from QGRS mapper
XIST,cervical cancer,"qPCR, Western blot, Luciferase reporter assay, etc.",up-regulated,29909347,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891, 0.933, 0.836, 0.891, 0.772]",No similarity to any PQS (2G) from QGRS mapper,"9 (1 - 3G, 8 - C-rich)","[2.069 (3G); -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS from QGRS mapper
XLOC_000303 SLC44A3-AS1,cervical cancer,qPCR,up-regulated,30134241,"Sequence Note: The RefSeq transcript was derived from the reference genome assembly. The genomic coordinates were determined from alignments (SLC44A3-AS1).
",7 (SLC44A3-AS1),"SLC44A3-AS1 (NR_104131.2, NR_160779.1, NR_160780.1, NR_160781.1, NR_160782.1, NR_160783.1, NR_160784.1)","7, 26, 26, 6, 7, 5, 4 (SLC44A3-AS1)","7, 26, 26, 6, 7, 5, 4 (SLC44A3-AS1)","0, 0, 0, 0, 0, 0, 0 (SLC44A3-AS1)","0, 0, 0, 0, 0, 0, 0 (SLC44A3-AS1)",VALIDATED (SLC44A3-AS1),"7 (C-rich);
3 (1-3G, 2-C-rich);
3 (1-3G, 2-C-rich);
1 (C-rich);
0
1 (C-rich)","[-0.893, -0.78, -1.011,
-0.872, -0.824, -0.891,
-1.041 (C-rich)];

[0.851, 0.911 (3G); -0.911, -0.957 (C-rich)];

[0.851, 0.911 (3G); -0.911, -0.957 (C-rich)];

[-0.893 (C-rich)];

[-0.893 (C-rich)]
","No 3G PQS to compare in 
QGRS Mapper",0,0,No PQS found on G4 Hunter
ZEB1-AS1,cervical cancer,"qPCR, Western blot, other",up-regulated,30425516,,6,"NR_024284.1, NR_148975.1, NR_148976.1, NR_148977.1, NR_148978.1, NR_148979.1","7, 5, 11, 14, 5, 5","6, 5, 10, 12, 4, 4","1, 0, 1, 2, 1, 1

PQS 1 of 1st, 4th, 5th and 6th variants are same.
PQS of 3rd variant and PQS 2 of 4th variant are different from each other and other variants as well.","0, 0, 0, 0, 0, 0",REVIEWED,"8 (3 - 2G, 5 - C-rich);
5 (C-rich); 
8 (3 - 2G, 5 - C-rich), 
15 (5 - 2G, 10 - C-rich),
3 (2G), 
2 (2G)","[0.986, 0.931, 0.891  [2G]]; [-0.96, -0.924, -0.915, -0.953, -0.721  [C-rich]];

[-0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)];
 
[1.055, 0.863, 0.831 (2G);-0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)] ; 

[0.986, 0.931, 0.768, 0.935, 0.915 (2G); -0.863, -0.965, -0.725, -0.661,  -0.766, -0.964, -0.96, -0.924,  -0.958, -0.721 (C-rich)]; 

[0.986, 0.931, 0.911 (2G)];

 [0.986, 0.931 (2G)] ",No similarity to any PQS (2G) from QGRS mapper,"0;
0;
5 (3G);
0;
0;
0","0;
0; 
[1.37, 1.36, 1.362, 1.333, 1.391 (3G)]; 
0; 
0; 
0",No similarity to PQS from QGRS mapper
ZEB1-AS1,cervical cancer,"qPCR, Western blot, other",up-regulated,30253398,,6,"NR_024284.1, NR_148975.1, NR_148976.1, NR_148977.1, NR_148978.1, NR_148979.1","7, 5, 11, 14, 5, 5","6, 5, 10, 12, 4, 4","1, 0, 1, 2, 1, 1

PQS 1 of 1st, 4th, 5th and 6th variants are same.
PQS of 3rd variant and PQS 2 of 4th variant are different from each other and other variants as well.","0, 0, 0, 0, 0, 0",REVIEWED,"8 (3 - 2G, 5 - C-rich);
5 (C-rich); 
8 (3 - 2G, 5 - C-rich), 
15 (5 - 2G, 10 - C-rich),
3 (2G), 
2 (2G)","[0.986, 0.931, 0.891  [2G]]; [-0.96, -0.924, -0.915, -0.953, -0.721  [C-rich]];

[-0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)];
 
[1.055, 0.863, 0.831 (2G);-0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)] ; 

[0.986, 0.931, 0.768, 0.935, 0.915 (2G); -0.863, -0.965, -0.725, -0.661,  -0.766, -0.964, -0.96, -0.924,  -0.958, -0.721 (C-rich)]; 

[0.986, 0.931, 0.911 (2G)];

 [0.986, 0.931 (2G)] ",No similarity to any PQS (2G) from QGRS mapper,"0;
0;
5 (3G);
0;
0;
0","0;
0; 
[1.37, 1.36, 1.362, 1.333, 1.391 (3G)]; 
0; 
0; 
0",No similarity to PQS from QGRS mapper
ZFAS1,cervical cancer,qPCR,up-regulated,30738960,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11, 8, 10, 11, 4","2, 1, 2, 2, 0","0, 0, 0, 0, 0",REVIEWED,"2 (2G);
1 (2G);
2 (2G);
2 (2G);
0","[0.774, 0.628 (2G)];
[0.774 (2G)];
[0.774, 0.628 (2G)]; 
[0.774, 0.628 (2G)]; 
0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);
3 (3G);
3 (3G);
3 (3G);
0","[1.444, 1.438, 1.333 (3G)]; 
[1.444, 1.438, 1.333 (3G)]; 
[1.444, 1.438, 1.333 (3G)]; 
[1.444, 1.438, 1.333 (3G)];
0",No similarity to PQS from QGRS mapper
ZNF667-AS1,cervical cancer,"qPCR, Microarray, western blot",down-regulated,29243775,Also Known As: ZNF667-AS1; MORT,2,NR_036521.1; NR_036522.1,"8,4","8,4","0,0","0,0",VALIDATED,"7 (2-C-rich, 3-3G, 2-2G)
7 (2-C-rich, 3-3G, 2-2G)","[0.958, 1, 1.04, 0.911, 
0.733 (3G); -0.933, -0.776 (C-rich)];

[0.958, 1, 1.04, 0.911, 
0.733 (3G); -0.933, -0.776 (C-rich)];","No 3G PQS to compare in 
QGRS Mapper","1 (3G);
1 (3G)","[1.422 (3G)];

[1.422 (3G)]","No 3G PQS to compare in 
QGRS Mapper"
Total no. of LncRNAs having Validated and Reviewed RefSeq status,,,,,,,,,,,,,,,,,,
137,,,,,,,,,,,,,,,,,,
